TWI683842B - Method for producing a low-concentration gel by using a precursor gel cluster, and a gel obtained by the method - Google Patents

Method for producing a low-concentration gel by using a precursor gel cluster, and a gel obtained by the method Download PDF

Info

Publication number
TWI683842B
TWI683842B TW105107368A TW105107368A TWI683842B TW I683842 B TWI683842 B TW I683842B TW 105107368 A TW105107368 A TW 105107368A TW 105107368 A TW105107368 A TW 105107368A TW I683842 B TWI683842 B TW I683842B
Authority
TW
Taiwan
Prior art keywords
group
gel
polymer
gel precursor
manufacturing
Prior art date
Application number
TW105107368A
Other languages
Chinese (zh)
Other versions
TW201714925A (en
Inventor
酒井崇匡
鄭雄一
Original Assignee
國立大學法人東京大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立大學法人東京大學 filed Critical 國立大學法人東京大學
Publication of TW201714925A publication Critical patent/TW201714925A/en
Application granted granted Critical
Publication of TWI683842B publication Critical patent/TWI683842B/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33303Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group
    • C08G65/33306Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33331Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group
    • C08G65/33337Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group cyclic
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/24Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/244Stepwise homogeneous crosslinking of one polymer with one crosslinking system, e.g. partial curing
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/24Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246Intercrosslinking of at least two polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/16Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2210/00Compositions for preparing hydrogels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00Characterised by the use of unspecified polymers
    • C08J2300/10Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00Characterised by the use of unspecified polymers
    • C08J2300/10Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • C08J2300/104Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing oxygen atoms
    • C08J2300/105Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing oxygen atoms containing carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00Characterised by the use of unspecified polymers
    • C08J2300/10Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • C08J2300/106Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00Characterised by the use of unspecified polymers
    • C08J2300/14Water soluble or water swellable polymers, e.g. aqueous gels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2333/00Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
    • C08J2333/04Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters
    • C08J2333/06Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters of esters containing only carbon, hydrogen, and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C08J2333/10Homopolymers or copolymers of methacrylic acid esters
    • C08J2333/12Homopolymers or copolymers of methyl methacrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2371/00Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
    • C08J2371/02Polyalkylene oxides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2400/00Characterised by the use of unspecified polymers
    • C08J2400/10Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2400/00Characterised by the use of unspecified polymers
    • C08J2400/10Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • C08J2400/104Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing oxygen atoms
    • C08J2400/105Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing oxygen atoms containing carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2400/00Characterised by the use of unspecified polymers
    • C08J2400/10Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • C08J2400/106Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2433/00Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
    • C08J2433/04Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters
    • C08J2433/06Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters of esters containing only carbon, hydrogen, and oxygen, the oxygen atom being present only as part of the carboxyl radical
    • C08J2433/10Homopolymers or copolymers of methacrylic acid esters
    • C08J2433/12Homopolymers or copolymers of methyl methacrylate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2471/00Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
    • C08J2471/02Polyalkylene oxides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyethers (AREA)

Abstract

本發明之課題在於提供一種能夠以短時間製作且具有彈性模數或膨脹壓等經控制之物性之低濃度之高分子含量之凝膠。 An object of the present invention is to provide a low-concentration polymer content gel that can be produced in a short time and has controlled physical properties such as elastic modulus and swelling pressure.

本發明提供一種高分子凝膠之製造方法,其特徵在於:其係凝膠前驅體團相互交聯而形成三維網狀結構之高分子凝膠之製造方法,且包括:a)使未達臨界凝膠化濃度之單體單元或聚合物單元交聯而形成上述凝膠前驅體團之步驟,其中,上述凝膠前驅體團於儲存彈性模數G'與損失彈性模數G"具有G'<G"之關係性;及b)藉由利用交聯劑使上述凝膠前驅體團相互交聯而獲得具有三維網狀結構之凝膠之步驟。 The invention provides a method for manufacturing a polymer gel, which is characterized in that it is a method for manufacturing a polymer gel in which gel precursor groups are cross-linked with each other to form a three-dimensional network structure, and includes: a) making the criticality not reached The step of crosslinking the monomer unit or the polymer unit at a gelation concentration to form the gel precursor group, wherein the gel precursor group has G'in storage elastic modulus G'and loss elastic modulus G" The relationship of "G"; and b) The step of obtaining a gel with a three-dimensional network structure by cross-linking the aforementioned gel precursor groups with a cross-linking agent.

Description

使用凝膠前驅體團之低濃度凝膠之製造方法、及以該製造方法所得凝膠 Manufacturing method of low-concentration gel using gel precursor mass, and gel obtained by the manufacturing method

本發明係關於一種新穎之高分子水凝膠。 The invention relates to a novel polymer hydrogel.

近年來,具有網狀結構之高分子凝膠由於具有優異之保水能力及生物相容性等特性,故而將其作為人造組織或再生支架用材料等埋設於活體內之研究受到關注(非專利文獻1)。然而,高分子凝膠存在如下問題:於水中會由於因凝膠內部與外部環境之濃度差所產生之滲透壓或經時變化等所致之分解而膨脹,因此於埋設之周圍之組織引起壓迫損傷。 In recent years, polymer gels with a network structure have excellent water-retaining ability and biocompatibility, so they have been paid attention to as embedding in vivo as materials for artificial tissues or regenerative scaffolds (Non-Patent Literature) 1). However, polymer gels have the following problems: in water, they will swell due to decomposition due to osmotic pressure or time-dependent changes in the concentration difference between the internal and external environments of the gel, so the surrounding tissues will cause compression damage.

由於該膨脹壓與構成凝膠之高分子濃度之平方成正比,故而因膨潤所致之影響於高分子濃度較高之情形時變得特別顯著。即便為了降低膨潤率而提高交聯度,交聯亦會因經時變化而被切斷,故而降低高分子之濃度成為本質上之解決對策。然而,若將高分子濃度降低至不產生因膨潤所致之組織損傷之程度,則利用先前之高分子凝膠之製造方法較難以短時間製作凝膠。又,於高分子濃度較低而於凝膠化點附近之區域形成凝膠之情形時,彈性模數等物性劇烈變化,故而較難控制其物性。 Since the swelling pressure is proportional to the square of the polymer concentration constituting the gel, the effect due to swelling becomes particularly noticeable when the polymer concentration is high. Even if the degree of crosslinking is increased in order to reduce the swelling rate, the crosslinking will be cut due to changes over time, so reducing the polymer concentration becomes an essential solution. However, if the polymer concentration is reduced to the extent that no tissue damage due to swelling occurs, it is difficult to produce a gel in a short time using the previous method of manufacturing a polymer gel. In addition, when the polymer concentration is low and a gel is formed in a region near the gelation point, physical properties such as elastic modulus change drastically, so it is difficult to control the physical properties.

[先前技術文獻] [Prior Technical Literature] [非專利文獻] [Non-patent literature]

[非專利文獻1]Sakai等、Macromolecules、41、5379-5384、2008 [Non-Patent Document 1] Sakai et al., Macromolecules, 41, 5379-5384, 2008

[非專利文獻2]Kurakazu等、Macromolecules、43、3935-3940、2010 [Non-Patent Document 2] Kurakazu et al., Macromolecules, 43, 3935-3940, 2010

[非專利文獻2]Kamata等、Science、343、873-875、2014 [Non-Patent Document 2] Kamata et al., Science, 343, 873-875, 2014

因此,本發明之目的在於開發能夠避免埋設於活體內時之因膨潤所致之組織損傷之問題之凝膠及其製造方法,其課題在於提供一種能夠以短時間製作且具有彈性模數或膨脹壓等經控制之物性之低濃度之高分子含量之凝膠。 Therefore, the object of the present invention is to develop a gel capable of avoiding the problem of tissue damage caused by swelling when buried in a living body and a method of manufacturing the gel, and its object is to provide an elastic modulus or swelling that can be produced in a short time Press the gel of low concentration and high polymer content with controlled physical properties.

本發明者等人為了解決上述問題而進行努力研究,結果發現,藉由刻意地形成具有即將凝膠化前之狀態、更詳細而言儲存彈性模數G'比損失彈性模數G"小之狀態之凝膠前驅體團,並將其用作其後之凝膠化反應中之種,能夠使該凝膠前驅體團作為非常易凝膠化之聚合物單元發揮功能,而以短時間獲得具有經控制之物性之低高分子濃度之凝膠,從而完成本發明。 The inventors of the present invention conducted intensive research in order to solve the above-mentioned problems, and found that by deliberately forming a state having a state immediately before gelation, in more detail, the storage elastic modulus G'is smaller than the loss elastic modulus G" The gel precursor group in the state, and used as a seed in the subsequent gelation reaction, can make the gel precursor group function as a polymer unit that is very gelable, and can be obtained in a short time A low-molecular-weight gel with controlled physical properties completes the present invention.

即,本發明於一態樣中提供: That is, the present invention provides in one aspect:

(1)一種高分子凝膠之製造方法,其特徵在於:其係凝膠前驅體團相互交聯而形成三維網狀結構之高分子凝膠之製造方法,且包括:a)使未達臨界凝膠化濃度之單體單元或聚合物單元交聯而形成上述凝膠前驅體團之步驟,其中,上述凝膠前驅體團於儲存彈性模數G'與損失彈性模數G"具有G'<G"之關係性;及b)藉由利用交聯劑使上述凝膠 前驅體團相互交聯而獲得具有三維網狀結構之凝膠之步驟。 (1) A method for manufacturing a polymer gel, which is characterized in that it is a method for manufacturing a polymer gel in which gel precursor groups are cross-linked with each other to form a three-dimensional network structure, and includes: a) making the subcritical The step of crosslinking the monomer unit or the polymer unit at a gelation concentration to form the gel precursor group, wherein the gel precursor group has G'in storage elastic modulus G'and loss elastic modulus G" The relationship of <G"; and b) by using a cross-linking agent to make the above gel The step of cross-linking the precursor groups to obtain a gel with a three-dimensional network structure.

又,本發明之製造方法之較佳態樣提供: In addition, the preferred aspect of the manufacturing method of the present invention provides:

(2)如上述(1)之製造方法,其中上述損失彈性模數G"於1Hz之頻率下為0.005~5Pa之範圍; (2) The manufacturing method as described in (1) above, wherein the loss elastic modulus G" is in the range of 0.005 to 5 Pa at a frequency of 1 Hz;

(3)如上述(1)或(2)之製造方法,其中上述凝膠前驅體團具有1.5~2.5之碎形維度; (3) The manufacturing method as described in (1) or (2) above, wherein the gel precursor mass has a fragmented dimension of 1.5~2.5;

(4)如上述(1)至(3)中任一項之製造方法,其中上述凝膠前驅體團具有10~1000nm之範圍之直徑; (4) The manufacturing method according to any one of (1) to (3) above, wherein the gel precursor mass has a diameter in the range of 10 to 1000 nm;

(5)如上述(1)至(4)中任一項之製造方法,其中上述凝膠為50g/L以下之高分子含量; (5) The production method according to any one of (1) to (4) above, wherein the gel has a polymer content of 50 g/L or less;

(6)如上述(1)至(5)中任一項之製造方法,其中上述單體單元係具有乙烯基骨架者,或者上述聚合物單元具有聚乙二醇骨架或聚乙烯骨架; (6) The production method according to any one of (1) to (5) above, wherein the monomer unit has a vinyl skeleton, or the polymer unit has a polyethylene glycol skeleton or a polyethylene skeleton;

(7)如上述(1)至(6)中任一項之製造方法,其中上述凝膠前驅體團包含於側鏈或末端具有1個以上之親核性官能基之第1聚合物單元、及於側鏈或末端具有1個以上之親電子性官能基之第2聚合物單元; (7) The production method according to any one of (1) to (6) above, wherein the gel precursor group includes a first polymer unit having one or more nucleophilic functional groups at the side chain or terminal, And a second polymer unit having more than one electrophilic functional group on the side chain or terminal;

(8)如上述(7)之製造方法,其中上述親核性官能基選自由胺基、-SH、及-CO2PhNO2所組成之群,上述親電子性官能基選自由N-羥基-丁二醯亞胺(NHS)基、磺基丁二醯亞胺基、馬來醯亞胺基、鄰苯二甲醯亞胺基、咪唑基、丙烯醯基、及硝基苯基所組成之群; (8) The production method as described in (7) above, wherein the nucleophilic functional group is selected from the group consisting of amine group, -SH, and -CO 2 PhNO 2 , and the electrophilic functional group is selected from N-hydroxy- Composed of succinimide (NHS) group, sulfosuccinimide group, maleimide group, phthalimide group, imidazolyl group, acryloyl group, and nitrophenyl group group;

(9)如上述(7)或(8)之製造方法,其中上述凝膠前驅體團包含第1凝膠前驅體團及第2凝膠前驅體團,上述第1凝膠前驅體團之第1聚合物單元之含量比第2聚合物單元之含量多,上述第2凝膠前驅體團之第2聚合物單元之含量比第1聚合物單元之含量多; (9) The manufacturing method according to the above (7) or (8), wherein the gel precursor group includes a first gel precursor group and a second gel precursor group, and the first gel precursor group 1 The content of the polymer unit is greater than the content of the second polymer unit, and the content of the second polymer unit of the second gel precursor group is greater than the content of the first polymer unit;

(10)如上述(1)至(9)中任一項之製造方法,其中上述步驟b)以1小時以內之反應時間進行;及 (10) The manufacturing method according to any one of (1) to (9) above, wherein the above step b) is performed with a reaction time within 1 hour; and

(11)如上述(1)至(10)中任一項之製造方法,其中上述步驟b)中之交聯劑係雙(磺基丁二醯亞胺基)戊二酸酯(BS2G)或DL-二硫蘇糖醇(DTT)、或於末端具有硫醇基之合成肽。 (11) The production method according to any one of the above (1) to (10), wherein the crosslinking agent in the above step b) is bis(sulfobutadiimide)glutarate (BS 2 G ) Or DL-dithiothreitol (DTT), or a synthetic peptide with a thiol group at the end.

於另一態樣中,本發明關於凝膠前驅體團提供: In another aspect, the present invention provides:

(12)一種凝膠前驅體團,其係使未達臨界凝膠化濃度之單體單元或聚合物單元交聯而獲得者,且包含溶劑,於儲存彈性模數G'與損失彈性模數G"具有G'<G"之關係性; (12) A gel precursor group obtained by cross-linking monomer units or polymer units that have not reached the critical gelation concentration, and containing a solvent, storing the elastic modulus G'and the loss elastic modulus G" has the relationship of G'<G";

(13)如上述(12)之凝膠前驅體團,其中上述損失彈性模數G"於1Hz之頻率下為0.005~5Pa之範圍; (13) The gel precursor group as described in (12) above, wherein the loss elastic modulus G" is in the range of 0.005 to 5 Pa at a frequency of 1 Hz;

(14)如上述(12)或(13)之凝膠前驅體團,其中上述凝膠前驅體團具有1.5~2.5之碎形維度; (14) The gel precursor mass as described in (12) or (13) above, wherein the gel precursor mass has a fragmented dimension of 1.5-2.5;

(15)如上述(12)至(14)中任一項之凝膠前驅體團,其中上述凝膠前驅體團具有10~1000nm之範圍之直徑; (15) The gel precursor group according to any one of (12) to (14) above, wherein the gel precursor group has a diameter in the range of 10 to 1000 nm;

(16)如上述(12)至(15)中任一項之凝膠前驅體團,其中上述單體單元係具有乙烯基骨架者,或者上述聚合物單元具有聚乙二醇骨架或聚乙烯骨架; (16) The gel precursor group according to any one of (12) to (15) above, wherein the monomer unit has a vinyl skeleton, or the polymer unit has a polyethylene glycol skeleton or a polyethylene skeleton ;

(17)如上述(12)至(16)中任一項之凝膠前驅體團,其包含於側鏈或末端具有1個以上之親核性官能基之第1聚合物單元、及於側鏈或末端具有1個以上之親電子性官能基之第2聚合物單元;及 (17) The gel precursor group according to any one of (12) to (16) above, which includes a first polymer unit having at least one nucleophilic functional group at the side chain or terminal, and at the side A second polymer unit having more than one electrophilic functional group at the chain or terminal; and

(18)如上述(17)之凝膠前驅體團,其中上述親核性官能基選自由胺基、-SH、及-CO2PhNO2所組成之群,上述親電子性官能基選自由N-羥基-丁二醯亞胺(NHS)基、磺基丁二醯亞胺基、馬來醯亞胺基、鄰苯二甲醯亞胺基、咪唑基、丙烯醯基、及硝基苯基所組成之群。 (18) The gel precursor group of (17) above, wherein the nucleophilic functional group is selected from the group consisting of an amine group, -SH, and -CO 2 PhNO 2 , and the electrophilic functional group is selected from N -Hydroxy-succinimide (NHS) group, sulfosuccinimide group, maleimide group, phthalimide group, imidazolyl group, acryloyl group, and nitrophenyl group The group formed.

於又一態樣中,本發明關於高分子凝膠提供: In yet another aspect, the present invention provides:

(19)一種高分子凝膠,其係藉由如上述(1)至(11)中任一項之製造方法所獲得; (19) A polymer gel obtained by the production method as described in any one of (1) to (11) above;

(20)一種高分子凝膠,其特徵在於:其係藉由聚合物單元相互交聯而形成三維網狀結構者,且包含溶劑,具有50g/L以下之高分子含量、於1Hz之頻率下為1~10000Pa之儲存彈性模數G'、及1.5~3.0之碎形維度; (20) A polymer gel, characterized in that it is formed by cross-linking polymer units to form a three-dimensional network structure, and contains a solvent, has a polymer content of 50 g/L or less, and a frequency of 1 Hz It is the storage elastic modulus G'of 1~10000Pa and the broken dimension of 1.5~3.0;

(21)如上述(20)之高分子凝膠,其具有1~100Pa之損失彈性模數G"; (21) The polymer gel as described in (20) above, which has a loss elastic modulus G" of 1-100 Pa;

(22)如上述(20)或(21)之高分子凝膠,其中上述單體單元係具有乙烯基骨架者,或者上述聚合物單元具有聚乙二醇骨架或聚乙烯骨架; (22) The polymer gel according to (20) or (21) above, wherein the monomer unit has a vinyl skeleton, or the polymer unit has a polyethylene glycol skeleton or a polyethylene skeleton;

(23)如上述(20)至(22)中任一項之高分子凝膠,其中上述聚合物單元包含於側鏈或末端具有1個以上之親核性官能基之第1聚合物單元、及於側鏈或末端具有1個以上之親電子性官能基之第2聚合物單元; (23) The polymer gel according to any one of (20) to (22) above, wherein the polymer unit includes a first polymer unit having one or more nucleophilic functional groups at the side chain or terminal, And a second polymer unit having more than one electrophilic functional group on the side chain or terminal;

(24)如上述(23)之高分子凝膠,其中上述親核性官能基選自由胺基、-SH、及-CO2PhNO2所組成之群,上述親電子性官能基選自由N-羥基-丁二醯亞胺(NHS)基、磺基丁二醯亞胺基、馬來醯亞胺基、鄰苯二甲醯亞胺基、咪唑基、丙烯醯基、及硝基苯基所組成之群; (24) The polymer gel of (23) above, wherein the nucleophilic functional group is selected from the group consisting of amine groups, -SH, and -CO 2 PhNO 2 , and the electrophilic functional group is selected from N- Hydroxy-succinimide (NHS) group, sulfosuccinimide group, maleimide group, phthalimide group, imidazolyl group, propenyl group, and nitrophenyl group Formed group

(25)如上述(20)至(24)中任一項之高分子凝膠,其為於水溶液中30~40℃之範圍內之上述高分子凝膠之體積相對於凝膠製成時之體積為90~500%之體積變化之範圍之膨潤度,且具有0.001~5kPa之膨潤壓;及 (25) The polymer gel according to any one of (20) to (24) above, which is the volume of the polymer gel in the range of 30 to 40°C in the aqueous solution relative to the gel The swelling degree of the volume is in the range of 90~500% volume change, and has a swelling pressure of 0.001~5kPa; and

(26)如上述(25)之高分子凝膠,其中上述膨潤度為100~200%之範圍,上述膨潤壓為0.1~2kPa。 (26) The polymer gel of (25) above, wherein the swelling degree is in the range of 100 to 200%, and the swelling pressure is 0.1 to 2 kPa.

根據本發明,藉由刻意地將於即將凝膠化前之狀態下所形成之凝膠前驅體團用作種而使其凝膠化,能夠控制彈性模數或膨潤度等物 性,並以短時間製作低濃度之高分子含量之凝膠。藉此,可提供埋設於活體內之情形等時能夠避免因膨潤所致之組織損傷之問題之凝膠。該凝膠可應用於人造聲帶等活體內之封閉腔或半封閉腔。 According to the present invention, by deliberately using the gel precursor mass formed in the state immediately before gelation as a seed to gel it, it is possible to control the elastic modulus, swelling degree, etc. In a short time, a low concentration polymer content gel is produced in a short time. This can provide a gel that can avoid tissue damage caused by swelling when buried in a living body. The gel can be applied to closed or semi-closed cavities in living bodies such as artificial vocal cords.

圖1係表示本發明之製造方法之概要之示意圖。 FIG. 1 is a schematic diagram showing the outline of the manufacturing method of the present invention.

圖2係表示通常之凝膠化步驟中之彈性模數之時間變化之圖表。 Fig. 2 is a graph showing changes in elastic modulus over time in a general gelation step.

圖3係表示本發明之製造方法之步驟a)中之彈性模數之時間變化之圖表。 FIG. 3 is a graph showing the time change of the elastic modulus in step a) of the manufacturing method of the present invention.

圖4係表示本發明之製造方法之步驟b)中之彈性模數之時間變化之圖表。 FIG. 4 is a graph showing the time change of the elastic modulus in step b) of the manufacturing method of the present invention.

圖5係針對使用凝膠前驅體團1[TAPEG+TNPEG]之本發明之情形(△)與比較例(○),表示凝膠化時間之圖表。 FIG. 5 is a graph showing the gelation time for the case (△) and the comparative example (○) of the present invention using the gel precursor group 1 [TAPEG+TNPEG].

圖6係針對使用凝膠前驅體團2[SHPEG+MAPEG]之本發明之情形(○)與比較例(□),表示凝膠化時間之圖表。 FIG. 6 is a graph showing the gelation time for the case (○) and the comparative example (□) of the present invention using the gel precursor group 2 [SHPEG+MAPEG].

圖7係表示凝膠前驅體團1[TAPEG+TNPEG]之尺寸分佈之圖表。 7 is a graph showing the size distribution of gel precursor group 1 [TAPEG+TNPEG].

圖8係表示測定凝膠前驅體團1[TAPEG+TNPEG]之凝膠化臨界點下之動態黏度特性之結果之圖表。 FIG. 8 is a graph showing the results of measuring the dynamic viscosity characteristics at the gelation critical point of gel precursor group 1 [TAPEG+TNPEG].

圖9係表示凝膠前驅體團1[TAPEG+TNPEG]之碎形維度之圖表。 FIG. 9 is a graph showing the fragment dimension of gel precursor group 1 [TAPEG+TNPEG].

圖10係表示高分子凝膠1[TAPEG+TNPEG]中之彈性模數之高分子濃度依存性之圖表。 FIG. 10 is a graph showing the dependence of the polymer concentration of the elastic modulus in polymer gel 1 [TAPEG+TNPEG].

圖11係表示高分子凝膠2[SHPEG+MAPEG]中之彈性模數之高分子濃度依存性之圖表。 FIG. 11 is a graph showing the dependence of the polymer concentration on the elastic modulus in polymer gel 2 [SHPEG+MAPEG].

圖12係表示半封閉空間中之高分子凝膠1[TAPEG+TNPEG]之膨潤之時間變化之圖像。 FIG. 12 is an image showing the time change of the swelling of the polymer gel 1 [TAPEG+TNPEG] in a semi-closed space.

圖13係針對水凝膠2[SHPEG+MAPEG],表示測定膨潤壓之時間變化之結果之圖表。 FIG. 13 is a graph showing the results of measuring the time change of swelling pressure for hydrogel 2 [SHPEG+MAPEG].

以下,對本發明之實施形態進行說明。本發明之範圍不限制於該等說明,關於以下例示以外,亦可於無損本發明之主旨之範圍內適宜地變更而實施。 Hereinafter, an embodiment of the present invention will be described. The scope of the present invention is not limited to these descriptions. In addition to the following examples, it can be implemented with appropriate changes within the scope not detracting from the gist of the present invention.

圖1係表示本發明之製造方法之概要之示意圖。作為第1步驟,如圖1a)所示,使最終構成高分子凝膠之單體單元或聚合物單元(以下,將該等稱作「前驅體單元」。)暫且於即將凝膠化前之狀態下反應,形成具有尚未形成凝膠之結構、即溶膠狀態之聚合物團。並且,作為第2步驟,如圖1b)所示,其特徵在於:添加適當之交聯劑,使該等團(凝膠前驅體團)進一步反應,相互三維地交聯,藉此獲得作為最終產物之高分子凝膠。其中,凝膠前驅體團如下所述未必限於為同一組成之單一種之情形,亦可使用具有不同組成之多種凝膠前驅體團。 FIG. 1 is a schematic diagram showing the outline of the manufacturing method of the present invention. As the first step, as shown in FIG. 1 a ), the monomer unit or polymer unit that finally constitutes the polymer gel (hereinafter, this is referred to as “precursor unit”.) It reacts in a state to form a polymer group having a structure that has not yet formed a gel, that is, a sol state. And, as the second step, as shown in FIG. 1b), it is characterized by adding an appropriate cross-linking agent to further react the groups (gel precursor groups) to cross-link three-dimensionally with each other, thereby obtaining as the final The polymer gel of the product. Among them, the gel precursor group is not necessarily limited to a single composition of the same composition as described below, and multiple types of gel precursor groups with different compositions may also be used.

本發明係基於將該凝膠前驅體團用作所謂最終凝膠之前驅體或中間物這一新穎概念者。藉此發現,即便於低濃度之高分子含量之情形時,亦能夠以短時間形成凝膠,又,即便於低彈性區域亦能夠控制凝膠之彈性模數之對於先前技術而言困難之方法。其中,所謂「凝膠」通常係指高黏度下失去流動性之分散系。 The present invention is based on the novel concept of using the gel precursor group as a so-called final gel precursor or intermediate. From this, it was found that even in the case of a low concentration of polymer content, the gel can be formed in a short time, and that the elastic modulus of the gel can be controlled even in the low elastic region, which is a difficult method for the prior art . Among them, the so-called "gel" usually refers to a dispersion system that loses fluidity at high viscosity.

(1)凝膠前驅體團 (1) Gel precursor mass

如上所述,本發明中所使用之凝膠前驅體團係藉由於即將凝膠化前之狀態、即未達臨界凝膠化濃度之條件下使前驅體單元反應而獲得之溶膠狀聚合物團。其中,「臨界凝膠化濃度」意指於藉由特定之前驅體單元之交聯構建三維結構之凝膠之體系中為了達成該凝膠化所必需之前驅體單元之最低濃度,亦稱為最低凝膠化濃度。於本發明中,臨界凝膠化濃度這一用語中,例如除於使用2種以上之前驅體單元之體系中,其等整體之濃度未達到至凝膠化之濃度之情形外,亦包含僅1種前驅體單元之濃度較低之情形、即因各前驅體單元之比率非 當量而不產生凝膠化之情形。 As described above, the gel precursor group used in the present invention is a sol-like polymer group obtained by reacting the precursor unit under the condition before gelation, that is, the condition that the critical gelation concentration is not reached. . Among them, "critical gelation concentration" means the lowest concentration of precursor units necessary to achieve the gelation in a system in which a gel of a three-dimensional structure is constructed by crosslinking of specific precursor units. The lowest gelation concentration. In the present invention, the term critical gelation concentration includes, for example, in addition to the case where the system uses two or more precursor units, the overall concentration does not reach the gelation concentration. 1 case where the concentration of the precursor unit is low, that is, the ratio of each precursor unit is not Equivalent without gelling.

雖然該凝膠前驅體團具有前驅體單元相互鍵結或交聯之結構,但由於其為於尚未達到凝膠化之條件下所形成者,故而於前驅體單元中存在未反應狀態之取代基。藉由使該取代基於凝膠前驅體團間之反應中相互形成進一步之交聯,而獲得具有三維網狀結構之最終之高分子凝膠。 Although the gel precursor group has a structure in which the precursor units are bonded or cross-linked to each other, since they are formed under conditions that have not yet reached gelation, there are unreacted substituents in the precursor units . By making the substitution based on the formation of further cross-links in the reaction between the gel precursor groups, a final polymer gel with a three-dimensional network structure is obtained.

該凝膠前驅體團於儲存彈性模數G'與損失彈性模數G"具有G'<G"之關係性。如圖2所示,通常於凝膠化以前之聚合物中,損失彈性模數G"之值比儲存彈性模數G'大,其後,隨著凝膠化,該等物性值之大小顛倒而G'變大。並且,G'=G"之點為所謂凝膠化點。因此,凝膠前驅體團為G'<G"係指其為溶膠狀態,且尚未達到凝膠化之狀態。較佳為於1Hz之頻率下為G'<G"<100 G'。 The storage elastic modulus G'of the gel precursor mass and the loss elastic modulus G" have a relationship of G'<G". As shown in Fig. 2, usually in the polymer before gelation, the value of the loss elastic modulus G" is larger than the storage elastic modulus G', and thereafter, with the gelation, the values of the physical properties are reversed. G'becomes larger. And the point where G'=G" is the so-called gelation point. Therefore, if the gel precursor group is G'<G", it means that it is in a sol state and has not yet reached the state of gelation. Preferably, it is G'<G"<100 G'at a frequency of 1 Hz.

較佳為該凝膠前驅體團之G"於1Hz之頻率下為0.005~5Pa之範圍,更佳為0.01~1Pa,進而較佳為0.01~0.5Pa之範圍。該等彈性模數可使用流變儀等公知之測定機器,藉由動態黏彈性測定等公知之方法算出。 The G" of the gel precursor mass is preferably in the range of 0.005 to 5 Pa at a frequency of 1 Hz, more preferably in the range of 0.01 to 1 Pa, and even more preferably in the range of 0.01 to 0.5 Pa. The elastic modulus can use flow The well-known measuring equipment such as a transformer is calculated by a well-known method such as dynamic viscoelasticity measurement.

又,本發明中之凝膠前驅體團較佳為具有1.5~2.5之碎形維度。更佳為具有1.5~2.0之碎形維度。其中,所謂碎形維度係表示基於聚合物單元之交聯結構以何種程度接近三維結構之狀態之指標,其算出方法可參照「W.Hess,T.A.Vilgis,and H.H.Winter,Macromolecules 21,2536(1988)」。具體而言,例如可根據凝膠化點下之動態黏彈性特性之變化,使用動態定標理論而計算。 In addition, the gel precursor mass in the present invention preferably has a fragmented dimension of 1.5 to 2.5. More preferably, it has a broken dimension of 1.5~2.0. Among them, the so-called fractal dimension is an index based on how close the cross-linked structure of the polymer unit is to the state of the three-dimensional structure, and the calculation method can refer to "W. Hess, TA Vilgis, and HH Winter, Macromolecules 21,2536 ( 1988)". Specifically, for example, it can be calculated using the dynamic scaling theory based on the change in dynamic viscoelastic properties under the gelation point.

本發明中之凝膠前驅體團較佳為具有10~1000nm之直徑,更佳為具有50~200nm之直徑。又,較佳為,於其分佈中理想為具有100nm左右之直徑之凝膠前驅體團之存在比率最多。 The gel precursor mass in the present invention preferably has a diameter of 10 to 1000 nm, and more preferably has a diameter of 50 to 200 nm. In addition, it is preferable that the gel precursor groups having a diameter of about 100 nm exist in the distribution with the largest ratio.

用以形成凝膠前驅體團之前驅體單元只要為能夠藉由溶液中之 凝膠化反應(交聯反應等)而形成凝膠之單體或聚合物,則可根據最終之凝膠之用途或形狀等而使用於該技術領域中公知者。更詳細而言,較佳為於自凝膠前驅體團獲得之最終之凝膠中,能夠藉由聚合物相互交聯而形成網狀結構、特別是三維網狀結構之聚合物單元。 The precursor units used to form the gel precursor group can be The monomer or polymer that forms a gel by a gelation reaction (crosslinking reaction, etc.) can be used as known in the technical field according to the final use or shape of the gel. In more detail, it is preferable that in the final gel obtained from the gel precursor group, polymer units capable of forming a network structure, particularly a three-dimensional network structure, by polymer crosslinking with each other.

用以形成凝膠前驅體團之單體單元例如可列舉具有乙烯基骨架者。又,作為用以形成凝膠前驅體團之聚合物單元,代表性地可列舉具有多個聚乙二醇骨架之支鏈之聚合物種,特別較佳為具有4個聚乙二醇骨架之支鏈之聚合物種。包含該四支鏈型聚乙二醇骨架之凝膠通常作為Tetra-PEG凝膠所熟知,藉由分別於末端具有活性酯結構等親電子性官能基及胺基等親核性官能基之2種四支鏈高分子間之AB型交叉偶合反應而構建網狀結構網絡。關於Tetra-PEG凝膠,據此前之研究,報告有於200nm以下之尺寸區域高分子網絡無不均勻性而具有理想之均勻網狀結構(Matsunaga等,Macromolecules、Vol.42、No.4、pp.1344-1351、2009)。又,Tetra-PEG凝膠能夠利用各高分子溶液之簡單之二液混合簡便地當場製作,亦能夠藉由調節凝膠製備時之pH值或離子強度而控制凝膠化時間。並且,由於該凝膠係以PEG作為主要成分,故而生物相容性亦優異。 Examples of the monomer unit used to form the gel precursor group include those having a vinyl skeleton. In addition, as the polymer unit for forming the gel precursor group, representatively include polymer species having a branched chain of a plurality of polyethylene glycol skeletons, particularly preferably a branch having four polyethylene glycol skeletons Chain polymer species. Gels containing the four-branched polyethylene glycol backbone are generally known as Tetra-PEG gels. They have an electrophilic functional group such as an active ester structure at the end and a nucleophilic functional group such as an amine group. An AB-type cross-coupling reaction between four branched polymers to build a network structure network. Regarding Tetra-PEG gel, according to previous research, it has been reported that the polymer network in the size region below 200nm has no unevenness and has an ideal uniform network structure (Matsunaga et al., Macromolecules, Vol. 42, No. 4, pp .1344-1351, 2009). In addition, Tetra-PEG gel can be easily produced on the spot using a simple two-component mixing of each polymer solution, and the gelation time can also be controlled by adjusting the pH or ionic strength during gel preparation. Moreover, since this gel system uses PEG as a main component, it is also excellent in biocompatibility.

但,若為相互交聯而能夠形成網狀結構網絡者,則亦可使用聚乙二醇骨架以外之聚合物。例如,亦可使用甲基丙烯酸甲酯等具有聚乙烯骨架之聚合物。 However, if cross-linking is possible to form a network structure network, polymers other than the polyethylene glycol skeleton can also be used. For example, a polymer having a polyethylene skeleton such as methyl methacrylate can also be used.

未必限定於該等,但為了於最終之凝膠中形成網狀結構網絡,較佳為使形成凝膠前驅體團之上述聚合物單元中於側鏈或末端具有1個以上之親核性官能基之第1聚合物單元、及於側鏈或末端具有1個以上之親電子性官能基之第2聚合物單元之2種聚合物種反應而交聯之方法。其中,親核性官能基與親電子性官能基之合計較佳為5個以上。該等官能基進而較佳為存在於末端。又,凝膠前驅體團可為第1聚合 物單元之含量比第2聚合物單元之含量多之組成,或者亦可為第2聚合物單元之含量比第1聚合物單元之含量多之組成。如下所述,於較佳態樣中,可使此種組成不同之2種以上之凝膠前驅體團交聯而獲得高分子凝膠。 It is not necessarily limited to these, but in order to form a network structure network in the final gel, it is preferable that the polymer unit forming the gel precursor group has more than one nucleophilic function at the side chain or at the end A method in which two kinds of polymers of a first polymer unit of a group and a second polymer unit having at least one electrophilic functional group on a side chain or terminal react and crosslink. Among them, the total of nucleophilic functional groups and electrophilic functional groups is preferably 5 or more. These functional groups are preferably present at the terminal. Also, the gel precursor group may be the first polymerization The content of the material unit may be greater than the content of the second polymer unit, or the content of the second polymer unit may be greater than the content of the first polymer unit. As described below, in a preferred aspect, two or more kinds of gel precursor groups having different compositions can be cross-linked to obtain a polymer gel.

作為存在於聚合物單元中之親核性官能基,可列舉胺基、-SH、或-CO2PhNO2(Ph表示鄰、間、或對伸苯基)等,業者可適當使用公知之親核性官能基。親核性官能基較佳為-SH基。親核性官能基可分別相同亦可不同,但較佳為相同。藉由官能基相同,與形成交聯鍵之親電子性官能基之反應性變得均勻,變得易獲得具有均勻之立體結構凝膠。 Examples of the nucleophilic functional group present in the polymer unit include amine groups, -SH, or -CO 2 PhNO 2 (Ph represents o-, m-, or p-phenylene), and the like can be appropriately used by the industry. Nuclear functional group. The nucleophilic functional group is preferably a -SH group. The nucleophilic functional groups may be the same or different, but preferably the same. With the same functional group, the reactivity with the electrophilic functional group forming the crosslink bond becomes uniform, and it becomes easy to obtain a gel with a uniform three-dimensional structure.

作為存在於聚合物單元中之親電子性官能基,可使用活性酯基。作為此種活性酯基,可列舉N-羥基-丁二醯亞胺基(NHS)、磺基丁二醯亞胺基、馬來醯亞胺基、鄰苯二甲醯亞胺基、咪唑基、丙烯醯基或硝基苯基等,業者可適當使用其他公知之活性酯基。親電子性官能基較佳為馬來醯亞胺基。親電子性官能基可分別相同亦可不同,但較佳為相同。藉由官能基相同,與形成交聯鍵之親核性官能基之反應性變得均勻,變得易獲得具有均勻之立體結構之凝膠。 As the electrophilic functional group present in the polymer unit, an active ester group can be used. Examples of such active ester groups include N-hydroxy-succinimide (NHS), sulfosuccinimide, maleimide, phthalimide, and imidazolyl. , Propylene acetyl or nitrophenyl, etc., the industry can use other well-known active ester groups. The electrophilic functional group is preferably a maleimide group. The electrophilic functional groups may be the same or different, but preferably the same. By having the same functional group, the reactivity with the nucleophilic functional group forming the crosslink bond becomes uniform, and it becomes easy to obtain a gel with a uniform three-dimensional structure.

作為於末端具有親核性官能基之聚合物單元,較佳非限定之具體例例如可列舉具有4個聚乙二醇骨架之支鏈且於末端具有胺基之以下述式(I)所表示之化合物。 As a polymer unit having a nucleophilic functional group at the terminal, preferred non-limiting specific examples include a branch having 4 polyethylene glycol skeletons and an amine group at the terminal represented by the following formula (I) Of compounds.

Figure 105107368-A0202-12-0010-1
Figure 105107368-A0202-12-0010-1

式(I)中,R11~R14分別相同或不同,C1-C7伸烷基、C2-C7伸烯基、-NH-R15-、-CO-R15-、-R16-O-R17-、-R16-NH-R17-、-R16-CO2-R17-、-R16- CO2-NH-R17-、-R16-CO-R17-、或-R16-CO-NH-R17-,其中,R15表示C1-C7伸烷基,R16表示C1-C3伸烷基,R17表示C1-C5伸烷基。 In formula (I), R 11 to R 14 are the same or different, and C 1 -C 7 alkylene, C 2 -C 7 alkenyl, -NH-R 15 -, -CO-R 15 -, -R 16 -OR 17 -, -R 16 -NH-R 17 -, -R 16 -CO 2 -R 17 -, -R 16 -CO 2 -NH-R 17 -, -R 16 -CO-R 17 -, Or -R 16 -CO-NH-R 17 -, wherein R 15 represents C 1 -C 7 alkylene, R 16 represents C 1 -C 3 alkylene, R 17 represents C 1 -C 5 alkylene .

n11~n14可分別相同亦可不同。n11~n14之值越接近,越能夠獲得均勻之立體結構,成為高強度。因此,為了獲得高強度之凝膠,較佳為相同。若n11~n14之值過高,則凝膠之強度變弱,若n11~n14之值過低,則因化合物之立體阻礙而不易形成凝膠。因此,n11~n14可列舉25~250之整數值,較佳為35~180,進而較佳為50~115,尤佳為50~60。並且,作為其分子量,可列舉5×103~5×104Da,較佳為7.5×103~3×104Da,更佳為1×104~2×104Da。 n 11 ~ n 14 may be the same or different. The closer the values of n 11 to n 14 are , the more uniform the three-dimensional structure can be obtained and the higher the strength. Therefore, in order to obtain a high-strength gel, it is preferably the same. If the value of n 11 ~ n 14 is too high, the strength of the gel becomes weak. If the value of n 11 ~ n 14 is too low, it is not easy to form a gel due to the steric hindrance of the compound. Therefore, n 11 to n 14 may be an integer value of 25 to 250, preferably 35 to 180, more preferably 50 to 115, and particularly preferably 50 to 60. In addition, examples of the molecular weight include 5×10 3 to 5×10 4 Da, preferably 7.5×10 3 to 3×10 4 Da, and more preferably 1×10 4 to 2×10 4 Da.

上述式(I)中,R11~R14為連結官能基與核部分之連結部位。R11~R14可分別相同亦可不同,但為了製造具有均勻之立體結構之高強度凝膠,較佳為相同。R11~R14表示C1-C7伸烷基、C2-C7伸烯基、-NH-R15-、-CO-R15-、-R16-O-R17-、-R16-NH-R17-、-R16-CO2-R17-、-R16-CO2-NH-R17-、-R16-CO-R17-、或-R16-CO-NH-R17-。其中,R15表示C1-C7伸烷基。R16表示C1-C3伸烷基。R17表示C1-C5伸烷基。 In the above formula (I), R 11 to R 14 are the connection sites connecting the functional group and the core part. R 11 to R 14 may be the same or different, but in order to produce a high-strength gel with a uniform three-dimensional structure, it is preferably the same. R 11 ~R 14 represent C 1 -C 7 alkylene, C 2 -C 7 alkenyl, -NH-R 15 -, -CO-R 15 -, -R 16 -OR 17 -, -R 16- NH-R 17 -, -R 16 -CO 2 -R 17 -, -R 16 -CO 2 -NH-R 17 -, -R 16 -CO-R 17 -, or -R 16 -CO-NH-R 17 -. Among them, R 15 represents a C 1 -C 7 alkylene group. R 16 represents C 1 -C 3 alkylene. R 17 represents C 1 -C 5 alkylene.

其中,所謂「C1-C7伸烷基」係指可具有支鏈之碳數為1以上且7以下之伸烷基,係指直鏈C1-C7伸烷基或具有1個或2個以上支鏈之C2-C7伸烷基(包括支鏈在內之碳數為2以上且7以下)。C1-C7伸烷基之例為亞甲基、伸乙基、伸丙基、伸丁基。C1-C7伸烷基之例可列舉-CH2-、-(CH2)2-、-(CH2)3-、-CH(CH3)-、-(CH2)3-、-(CH(CH3))2-、-(CH2)2-CH(CH3)-、-(CH2)3-CH(CH3)-、-(CH2)2-CH(C2H5)-、-(CH2)6-、-(CH2)2-C(C2H5)2-、及-(CH2)3C(CH3)2CH2-等。 Among them, the so-called "C 1 -C 7 alkylene" refers to an alkylene group which may have a branched carbon number of 1 or more and 7 or less, refers to a linear C 1 -C 7 alkylene or has 1 or Two or more branched C 2 -C 7 alkylene groups (including the branched carbon number of 2 or more and 7 or less). Examples of C 1 -C 7 alkylene are methylene, ethyl, propyl, and butyl. Examples of C 1 -C 7 alkylene extenders include -CH 2 -, -(CH 2 ) 2 -, -(CH 2 ) 3 -, -CH(CH 3 )-, -(CH 2 ) 3 -,- (CH(CH 3 )) 2 -, -(CH 2 ) 2 -CH(CH 3 )-, -(CH 2 ) 3 -CH(CH 3 )-, -(CH 2 ) 2 -CH(C 2 H 5 )-, -(CH 2 ) 6 -, -(CH 2 ) 2 -C(C 2 H 5 ) 2 -, and -(CH 2 ) 3 C(CH 3 ) 2 CH 2 -, etc.

所謂「C2-C7伸烯基」係指於鏈中具有1個或2個以上雙鍵之狀或支鏈狀之碳原子數2~7個之伸烯基,例如可列舉具有自上述伸烷基中除去相鄰之碳原子之2~5個氫原子所形成之雙鍵之2價基。 The so-called "C 2 -C 7 alkenyl group" refers to an alkenyl group having 2 to 7 carbon atoms in the shape of a chain or branched chain having one or more than two double bonds in the chain. The divalent group of the double bond formed by removing 2 to 5 hydrogen atoms of adjacent carbon atoms in the alkylene group.

另一方面,作為於末端具有親電子性官能基之聚合物單元,較 佳非限定之具體例例如可列舉具有4個聚乙二醇骨架之支鏈且於末端具有N-羥基-丁二醯亞胺(NHS)基之以下述式(II)所表示之化合物。 On the other hand, as a polymer unit having an electrophilic functional group at the end, it is Preferred non-limiting specific examples include, for example, compounds represented by the following formula (II) having a branched chain of four polyethylene glycol skeletons and an N-hydroxy-succinimide (NHS) group at the terminal.

Figure 105107368-A0202-12-0012-2
Figure 105107368-A0202-12-0012-2

上述式(II)中,n21~n24可分別相同或亦可不同。n21~n24之值越接近,凝膠越能夠獲得均勻之立體結構,成為高強度,故而較佳,因而較佳為相同。若n21~n24之值過高,則凝膠之強度變弱,若n21~n24之值過低,則因化合物之立體阻礙而不易形成凝膠。因此,n21~n24可列舉5~300之整數值,較佳為20~250,更佳為30~180,進而較佳為45~115,進而更佳為45~55。作為本發明之第2四支鏈化合物之分子量,可列舉5×103~5×104Da,較佳為7.5×103~3×104Da,更佳為1×104~2×104Da。 In the above formula (II), n 21 to n 24 may be the same or different. The closer the value of n 21 ~ n 24, the more the gel can obtain a uniform three-dimensional structure and become a high strength, so it is better, and therefore preferably the same. If the value of n 21 ~ n 24 is too high, the strength of the gel becomes weak. If the value of n 21 ~ n 24 is too low, it is not easy to form a gel due to the steric hindrance of the compound. Therefore, n 21 to n 24 may be an integer value of 5 to 300, preferably 20 to 250, more preferably 30 to 180, further preferably 45 to 115, and still more preferably 45 to 55. The molecular weight of the second four-branched compound of the present invention includes 5×10 3 to 5×10 4 Da, preferably 7.5×10 3 to 3×10 4 Da, and more preferably 1×10 4 to 2× 10 4 Da.

上述式(II)中,R21~R24為連結官能基與核部分之連結部位。R21~R24可分別相同亦可不同,但為了製造具有均勻之立體結構之高強度凝膠,較佳為相同。式(II)中,R21~R24分別相同或不同,表示C1-C7伸烷基、C2-C7伸烯基、-NH-R25-、-CO-R25-、-R26-O-R27-、-R26-NH-R27-、-R26-CO2-R27-、-R26-CO2-NH-R17-、-R26-CO-R27-、或-R26-CO-NH-R27-。其中,R25表示C1-C7伸烷基。R26表示C1-C3伸烷基。R27表示C1-C5伸烷基。 In the above formula (II), R 21 to R 24 are the connection sites connecting the functional group and the core part. R 21 ~ R 24 may be the same or different, but in order to produce a high-strength gel with a uniform three-dimensional structure, it is preferably the same. In formula (II), R 21 to R 24 are the same or different, and represent C 1 -C 7 alkylene, C 2 -C 7 alkenyl, -NH-R 25 -, -CO-R 25 -,- R 26 -OR 27 -, -R 26 -NH-R 27 -, -R 26 -CO 2 -R 27 -, -R 26 -CO 2 -NH-R 17 -, -R 26 -CO-R 27- , Or -R 26 -CO-NH-R 27 -. Among them, R 25 represents a C 1 -C 7 alkylene group. R 26 represents C 1 -C 3 alkylene. R 27 represents C 1 -C 5 alkylene.

於本說明書中,伸烷基及伸烯基亦可具有1個以上任意之取代基。作為該取代基,例如可列舉烷氧基、鹵素原子(可為氟原子、氯原子、溴原子、或碘原子中之任一者)、胺基、單一或二取代胺基、 取代矽烷基、醯基、或芳基等,但不限定於此。於烷基具有2個以上之取代基之情形時,其等可相同亦可不同。關於包含烷基部分之其他取代基(例如烷氧基或芳烷基等)之烷基部分亦相同。 In this specification, the alkylene group and the alkenyl group may have one or more arbitrary substituents. Examples of the substituent include an alkoxy group, a halogen atom (which may be any of a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom), an amine group, a single or disubstituted amine group, Substitute silane group, acetyl group, or aryl group, etc., but not limited thereto. When the alkyl group has two or more substituents, they may be the same or different. The same applies to the alkyl portion of other substituents (such as alkoxy or aralkyl groups) containing an alkyl portion.

又,於本說明書中,於將某官能基定義為「可具有取代基」之情形時,取代基之種類、取代位置、及取代基之個數並無特別限定,於具有2個以上取代基之情形時,其等可相同亦可不同。作為取代基,例如可列舉烷基、烷氧基、羥基、羧基、鹵素原子、磺基、胺基、烷氧羰基、側氧基等,但不限定於該等。該等取代基上亦可進而存在取代基。 In addition, in this specification, when a certain functional group is defined as "may have a substituent", the type, substitution position, and number of substituents of the substituent are not particularly limited, but have 2 or more substituents In this case, they may be the same or different. Examples of the substituent include an alkyl group, an alkoxy group, a hydroxyl group, a carboxyl group, a halogen atom, a sulfo group, an amine group, an alkoxycarbonyl group, and a pendant oxygen group, but are not limited thereto. There may be further substituents on these substituents.

於上述式(I)及式(II)之聚合物單元之情形時,可獲得其等藉由醯胺鍵連結之結構之凝膠前驅體團。再者,如下所述,於此情形時,於最終獲得之凝膠中,亦成為各聚合物單元藉由醯胺鍵交聯之結構。 In the case of the polymer unit of the above formula (I) and formula (II), a gel precursor group whose structure is connected by an amide bond can be obtained. Furthermore, as described below, in this case, in the gel finally obtained, each polymer unit is also a structure cross-linked by an amide bond.

(2)凝膠化步驟 (2) Gelation step

作為本發明之製造方法中之凝膠化反應步驟之典型態樣,包括:a)使未達臨界凝膠化濃度之單體單元或聚合物單元(前驅體單元)交聯而形成成為凝膠前驅體之團之步驟(圖1a);b)藉由利用交聯劑使上述凝膠前驅體團相互交聯而獲得作為最終目標物之具有三維網狀結構之凝膠之步驟(圖1b)。 As a typical aspect of the gelation reaction step in the manufacturing method of the present invention, it includes: a) crosslinking monomer units or polymer units (precursor units) that have not reached the critical gelation concentration to form a gel The step of the precursor group (Figure 1a); b) The step of obtaining a gel with a three-dimensional network structure as the final target by cross-linking the aforementioned gel precursor groups with a cross-linking agent (Figure 1b) .

於步驟a)中,如上所述,藉由調節前驅體單元之初期濃度,於未達臨界凝膠化濃度之條件下使前驅體單元反應,而形成未達到凝膠化之溶膠狀態、較佳為具有即將凝膠化前之結構之聚合物之團。該團可謂為相對於最終凝膠而言之前驅體,因此於本申請案中,將該團稱為「凝膠前驅體團」。 In step a), as described above, by adjusting the initial concentration of the precursor unit, the precursor unit is reacted under the condition that the critical gelation concentration is not reached to form a sol state that has not reached gelation, preferably It is a mass of polymer with a structure just before gelation. This group can be described as a precursor relative to the final gel, so in this application, this group is referred to as a "gel precursor group".

作為將前驅體單元之初期濃度調節至未達臨界凝膠化濃度之條件之方法,例如於如上述使用具有親核性官能基或親電子性官能基之 2種聚合物單元之情形時,可使用:按當量包含該等但作為整體未完全達到凝膠化之低濃度條件;或者藉由使1種聚合物單元之濃度為低濃度、即設為非當量而不產生凝膠化之條件。 As a method for adjusting the initial concentration of the precursor unit to a condition that does not reach the critical gelation concentration, for example, when using a nucleophilic functional group or an electrophilic functional group as described above In the case of 2 types of polymer units, it can be used: the equivalent concentration is included but the gel concentration as a whole has not reached the low concentration condition; or by setting the concentration of 1 type of polymer unit to a low concentration, it is set to non- Equivalent conditions without gelation.

通常,臨界凝膠化濃度(最低凝膠化濃度)取決於所使用之前驅體單元之種類,但該濃度於該技術領域中公知,業者可於以實驗之方式容易地掌握。典型的是5~50g/L,下限為重疊濃度之1/5左右之濃度。其中,重疊濃度為聚合物單元填充至溶液中之濃度,其算出方法例如可參照Polymer Physics(M.Rubinstein,R.Colby著)。具體而言,例如可藉由稀溶液之黏度測定,使用弗洛里-福克斯方程式而求得。 Generally, the critical gelation concentration (minimum gelation concentration) depends on the type of precursor unit used, but the concentration is well known in the technical field and can be easily grasped by an experimenter by experiment. Typical is 5~50g/L, and the lower limit is about 1/5 of the overlapping concentration. The overlapping concentration is the concentration of the polymer unit filled in the solution. For the calculation method, for example, refer to Polymer Physics (by M. Rubinstein, R. Colby). Specifically, for example, it can be obtained by measuring the viscosity of a dilute solution and using the Flory-Fox equation.

步驟a)典型而言可藉由混合包含2種前驅體單元之溶液或施加刺激而進行。又,亦可藉由使用自由基起始劑之單體之自由基聚合而進行。各溶液之濃度、添加速度、混合速度、混合比率並無特別限定,業者可適當地調整。又可知,於使用3種以上前驅體單元之情形時,亦可同樣地製備包含對應之前驅體單元之溶液,並將其等適當地混合。作為包含前驅體單元之溶液之溶劑,可使用水、乙醇等醇類、DMSO(Dimethyl sulfoxide,二甲基亞碸)等。於該溶液為水溶液之情形時,可使用磷酸緩衝液等適當之pH值緩衝液。 Step a) can typically be performed by mixing a solution containing 2 precursor units or applying a stimulus. Moreover, it can also be performed by radical polymerization of the monomer using a radical initiator. The concentration, addition speed, mixing speed, and mixing ratio of each solution are not particularly limited, and can be appropriately adjusted by the manufacturer. It can also be seen that, when three or more precursor units are used, a solution containing the corresponding precursor units can be prepared in the same manner and appropriately mixed. As the solvent of the solution containing the precursor unit, alcohols such as water and ethanol, DMSO (Dimethyl sulfoxide, dimethyl sulfoxide), etc. can be used. When the solution is an aqueous solution, an appropriate pH buffer such as phosphate buffer can be used.

作為混合之方法,例如可使用如國際公開WO2007/083522號公報所揭示之二液混合注射器而進行。混合時之二液之溫度並無特別限定,只要為使前驅體單元分別溶解,各液為具有流動性之狀態之溫度即可。例如,作為混合時之溶液之溫度,可列舉1℃~100℃之範圍。二液之溫度亦可不同,但溫度相同時二液易混合,故而較佳。 As a method of mixing, for example, a two-liquid mixing syringe as disclosed in International Publication WO2007/083522 can be used. The temperature of the two liquids at the time of mixing is not particularly limited, as long as the precursor units are dissolved separately, and each liquid may be in a state of fluidity. For example, as the temperature of the solution at the time of mixing, the range of 1°C to 100°C may be mentioned. The temperature of the two liquids can also be different, but when the temperature is the same, the two liquids are easy to mix, so it is better.

其次,於步驟b)中,使於步驟a)中獲得之凝膠前驅體團進一步反應,使其相互三維地交聯,藉此獲得作為最終產物之高分子凝膠。如上所述,由於凝膠前驅體團形成為凝膠化點以前之狀態,故而用於各前驅體單元中之交聯之取代基以未反應之狀態殘存。藉由使凝膠前驅 體團中之該取代基與其他凝膠前驅體團之殘存取代基反應、交聯而形成最終之凝膠。 Next, in step b), the gel precursor groups obtained in step a) are further reacted to crosslink them three-dimensionally, thereby obtaining a polymer gel as a final product. As described above, since the gel precursor group is formed in a state before the gelation point, the substituent used for crosslinking in each precursor unit remains in an unreacted state. By making the gel precursor The substituent in the mass reacts with the remaining substituents of other gel precursors to form a final gel.

較佳為,於該步驟b)中,可添加用以使凝膠前驅體團相互交聯之交聯劑或施加刺激。作為此種交聯劑,可使用具有與聚合物單元中之交聯基相同之取代基者,亦可將聚合物單元本身用作交聯劑而追加添加。例如,於步驟a)中,於使具有親核性官能基或親電子性官能基之2種聚合物單元以非當量反應而獲得凝膠前驅體團之情形時,藉由添加具有濃度更少之官能基之交聯劑,可使凝膠前驅體團間進行交聯。作為此種交聯劑,可使用雙(磺基丁二醯亞胺基)戊二酸酯(BS2G)或DL-二硫蘇糖醇(DTT)、或於末端具有硫醇基之合成肽等。又,作為用於交聯之刺激,例如可對引起光二聚化之官能基(馬來醯亞胺基等)照射紫外光。 Preferably, in this step b), a cross-linking agent for cross-linking the gel precursor groups may be added or a stimulus may be applied. As such a crosslinking agent, those having the same substituent as the crosslinking group in the polymer unit can be used, or the polymer unit itself can be used as a crosslinking agent and added additionally. For example, in step a), when two polymer units having a nucleophilic functional group or an electrophilic functional group are reacted in an unequivalent amount to obtain a gel precursor group, by adding The cross-linking agent of the functional group can cross-link the gel precursor groups. As such a crosslinking agent, bis(sulfosuccinimide) glutarate (BS 2 G) or DL-dithiothreitol (DTT), or a synthesis having a thiol group at the terminal can be used Peptides, etc. In addition, as a stimulus for crosslinking, for example, a functional group (maleimide group, etc.) that causes photodimerization may be irradiated with ultraviolet light.

較佳為,於步驟b)中,能夠以2小時以內之反應時間、較佳為1小時以內之反應時間獲得最終之凝膠。通常於製作以低濃度包含高分子之凝膠之情形時,需要長時間之反應時間(亦取決於體系,例如於高分子含量為10g/L以下之情形時約8小時),相對於此,於本發明中,能夠以非常短之時間製作凝膠。 Preferably, in step b), the final gel can be obtained with a reaction time within 2 hours, preferably within 1 hour. Generally, when making a gel containing a polymer at a low concentration, a long reaction time is required (depending on the system, for example, about 8 hours when the polymer content is 10 g/L or less), compared to this, In the present invention, the gel can be produced in a very short time.

步驟b)中之其他反應溶液條件等與步驟a)相同。 The conditions of the other reaction solutions in step b) are the same as in step a).

(3)高分子凝膠 (3) Polymer gel

藉由本發明所獲得之高分子凝膠係聚合物含量為低濃度,且如上述能夠以較短之反應時間獲得,並能夠將彈性模數等物性控制於所需範圍者。如圖2所示,通常於凝膠化點附近之彈性模數急遽上升,因此難以獲得於10~1000Pa等低彈性模數之範圍內控制為特定值之低彈性模數之凝膠。相對於此,本發明之凝膠由於係經由上述凝膠前驅體團而製作凝膠,故而具有控制於低彈性區域之彈性模數。 The polymer gel-based polymer obtained by the present invention has a low concentration, can be obtained with a short reaction time as described above, and can control the physical properties such as elastic modulus within a desired range. As shown in FIG. 2, the elastic modulus generally increases sharply near the gelation point, so it is difficult to obtain a low elastic modulus gel controlled to a specific value within a low elastic modulus range of 10 to 1000 Pa. In contrast, the gel of the present invention has a modulus of elasticity controlled in a low-elasticity region because the gel is produced through the aforementioned gel precursor group.

因此,本發明之高分子凝膠之特徵在於:其係藉由聚合物單元 相互交聯而形成三維網狀結構者,且具有低濃度之高分子含量、低區域之彈性模數、及特定之碎形維度。 Therefore, the polymer gel of the present invention is characterized in that it is composed of polymer units Cross-linked to form a three-dimensional network structure, and has a low concentration of polymer content, a low area of elastic modulus, and a specific broken dimension.

本發明之高分子凝膠中之高分子含量為50g/L以下,較佳為40g/L以下,更佳為15~30g/L。 The polymer content of the polymer gel of the present invention is 50 g/L or less, preferably 40 g/L or less, and more preferably 15 to 30 g/L.

本發明之高分子凝膠具有1~10000Pa、較佳為10~1000Pa之儲存彈性模數G'。該範圍係對應活體中之玻璃體(數10Pa)或聲帶(數100Pa)者。又,較佳為本發明之高分子凝膠具有1~100Pa之損失彈性模數G"。該等彈性模數可使用公知之測定機器,藉由公知之方法算出。 The polymer gel of the present invention has a storage elastic modulus G'of 1~10000Pa, preferably 10~1000Pa. This range corresponds to the vitreous body (number 10Pa) or vocal cord (number 100Pa) in the living body. In addition, it is preferable that the polymer gel of the present invention has a loss elastic modulus G" of 1 to 100 Pa. These elastic modulus can be calculated by a known method using a known measuring machine.

進而,本發明之高分子凝膠較佳為具有1.5~2.5之碎形維度。更佳為具有1.5~2.0之碎形維度。該碎形維度係表示凝膠中之交聯結構以何種程度接近三維結構之狀態之指標,其算出方法如上所述,於該技術領域中為公知。 Furthermore, the polymer gel of the present invention preferably has a broken dimension of 1.5 to 2.5. More preferably, it has a broken dimension of 1.5~2.0. The fragmented dimension is an index indicating how close the cross-linked structure in the gel is to the state of the three-dimensional structure. The calculation method is as described above and is well known in the technical field.

本發明之高分子凝膠為於水溶液中30~40℃之範圍內之上述高分子凝膠之體積相對於凝膠製成時之體積為90~500%之體積變化之範圍之膨潤度,且具有0.001~5kPa之膨潤壓。較佳為上述膨潤度為100~200%之範圍,膨潤壓為0.1~2kPa。膨潤壓較低係指將凝膠置於密閉空間時向外部施加之壓力較低。即,係指即便於在活體內隨時間經過吸收水分而膨脹之情形時,組織損傷性亦較低。 The polymer gel of the present invention is the swelling degree of the volume of the polymer gel in the range of 30-40°C in the aqueous solution in the range of 90-500% of the volume change with respect to the volume when the gel is made, and With swelling pressure of 0.001~5kPa. Preferably, the swelling degree is in the range of 100 to 200%, and the swelling pressure is 0.1 to 2 kPa. Lower swelling pressure means that the pressure applied to the outside is lower when the gel is placed in an enclosed space. That is, it means that even when the body absorbs water and swells over time, the tissue damage is low.

構成本發明之高分子凝膠之聚合物單元可使用與上述之凝膠前驅體團之情形相同者。於較佳態樣中,於凝膠前驅體團包含於側鏈或末端具有1個以上親核性官能基之第1聚合物單元、及於側鏈或末端具有1個以上親電子性官能基之第2聚合物單元之情形時,該凝膠前驅體團可使用作為第1聚合物單元之含量比第2聚合物單元之含量多之組成之第1凝膠前驅體團、及作為第2聚合物單元之含量比第1聚合物單元之含量多之組成之第2凝膠前驅體團之2種凝膠前驅體團,從而可為該 等組成不同之2種凝膠前驅體團相互交聯而成之三維網狀結構之高分子凝膠。 The polymer unit constituting the polymer gel of the present invention can be the same as the case of the gel precursor group described above. In a preferred aspect, the gel precursor group includes a first polymer unit having more than one nucleophilic functional group on the side chain or terminal, and has more than one electrophilic functional group on the side chain or terminal In the case of the second polymer unit, the gel precursor group can be used as the first gel precursor group of a composition in which the content of the first polymer unit is greater than the content of the second polymer unit, and as the second The two kinds of gel precursor groups of the second gel precursor group composed of the polymer unit whose content is more than the content of the first polymer unit can be the It is a polymer gel with a three-dimensional network structure formed by crosslinking two kinds of gel precursor groups with different compositions.

本發明之高分子凝膠可根據其用途而加工成薄膜狀等各種形狀。此種加工可使用於該技術領域中所知之任意方法。例如,於薄膜之情形時,例如可藉由於凝膠完全固化前之具有流動性之狀態下塗佈於玻璃等平面基板上等方法而獲得薄膜。 The polymer gel of the present invention can be processed into various shapes such as a film shape according to its application. Such processing can be applied to any method known in the technical field. For example, in the case of a thin film, the thin film can be obtained, for example, by coating on a flat substrate such as glass with fluidity before the gel is completely cured.

[實施例] [Example]

以下,藉由實施例進一步詳細地說明本發明,但本發明並不受該等之限定。 Hereinafter, the present invention will be described in further detail by examples, but the present invention is not limited to these.

[實施例1] [Example 1]

聚合物單元之合成Synthesis of polymer units

藉由使於末端具有羥基之THPEG(四羥基-聚乙二醇)分別胺基化、丁二醯亞胺基化而獲得TAPEG(四胺-聚乙二醇)及TNPEG(N-羥基-丁二醯亞胺基-聚乙二醇(NHS-PEG))。 TAPEG (tetraamine-polyethylene glycol) and TNPEG (N-hydroxy-butane) are obtained by amination of THPEG (tetrahydroxy-polyethylene glycol) having a hydroxyl group at the terminal and iminoylation of succinimide, respectively. Diimino-polyethylene glycol (NHS-PEG)).

又,於末端具有-SH基之SHPEG(四硫醇-聚乙二醇)及於末端具有馬來醯亞胺基之MAPEG(四馬來醯亞胺基-聚乙二醇)分別使用由日油股份有限公司市售者。分子量均為10,000。 In addition, SHPEG (tetrathiol-polyethylene glycol) having a -SH group at the end and MAPEG (tetramaleimide-polyethylene glycol) having a maleimide group at the end are used by Japan Marketer of Oil Co., Ltd. The molecular weight is 10,000.

於以下之實驗中,1H NMR光譜係使用日本電子之JNM-ECS400(400MHz)進行解析。將氘氯仿用作溶劑,將四甲基矽烷設為內部標準。分子量係使用Bruker Daltonics之質譜儀Ultraflex III之線性陽離子模式而確定。 In the following experiment, the 1 H NMR spectrum was analyzed using JNM-ECS400 (400 MHz) from JEOL. Deuterochloroform was used as the solvent, and tetramethylsilane was set as the internal standard. The molecular weight is determined using the linear cation mode of Bruflex Daltonics' mass spectrometer Ultraflex III.

1. THPEG之合成: 1. Synthesis of THPEG:

將起始劑之季戊四醇(0.4572mmol、62.3mg)溶解於DMSO/THF(v/v=3:2)50mL之混合溶劑,金屬化劑使用萘鉀(0.4157mmol、1.24mg),添加環氧乙烷(200mmol、10.0mL),於Ar存在下且60℃下加熱攪拌約2天。反應結束後,使其於二乙醚中再沈澱,藉 由過濾提取沈澱物。進而,利用二乙醚洗淨3次,將獲得之白色固體減壓乾燥,藉此獲得20k之THPEG。 Dissolve the initiator pentaerythritol (0.4572mmol, 62.3mg) in a mixed solvent of 50mL of DMSO/THF (v/v=3:2), use potassium naphthalene (0.4157mmol, 1.24mg) as the metallizing agent, add ethylene oxide Alkanes (200 mmol, 10.0 mL) were heated and stirred at 60° C. for about 2 days in the presence of Ar. After the reaction, let it reprecipitate in diethyl ether The precipitate is extracted by filtration. Furthermore, it was washed three times with diethyl ether, and the obtained white solid was dried under reduced pressure, thereby obtaining 20 k of THPEG.

2. TAPEG之合成: 2. Synthesis of TAPEG:

將THPEG(0.1935mmol、3.87g、1.0equiv)溶解於苯中並使其冷凍乾燥後,溶解於THF 62mL,添加三乙基胺(TEA)(0.1935mmol、3.87g、1.0equiv)。於另一圓底燒瓶中添加THF 31mL及甲磺醯氯(MsCl)(0.1935mmol、3.87g、1.0equiv),置於冰浴中。將MsCl之THF溶液歷時約1分鐘滴加至THPEG、TEA之THF溶液中,於冰浴中攪拌30分鐘後,於室溫下攪拌1.5小時。反應結束後,使其於二乙醚中再沈澱,藉由過濾提取沈澱物。進而,利用二乙醚洗淨3次,將所獲得之白色固體移至圓底燒瓶,加入25%之氨水250mL,攪拌4天。反應結束後,藉由蒸發器將溶劑減壓蒸餾去除,將水向外液進行2、3次透析,並進行冷凍乾燥,藉此獲得白色固體之TAPEG。製作之TAPEG之化學式示於式(Ia)。式(Ia)中,關於n11~n14,於TAPEG之分子量為約10,000(10kDa)時為50~60,於分子量為約20,000(20kDa)時為100~115。 After THPEG (0.1935 mmol, 3.87 g, 1.0 equiv) was dissolved in benzene and lyophilized, it was dissolved in 62 mL of THF, and triethylamine (TEA) (0.1935 mmol, 3.87 g, 1.0 equiv) was added. In another round bottom flask, 31 mL of THF and mesyl chloride (MsCl) (0.1935 mmol, 3.87 g, 1.0 equiv) were added and placed in an ice bath. The THF solution of MsCl was added dropwise to the THF solution of THPEG and TEA over about 1 minute, stirred for 30 minutes in an ice bath, and then stirred at room temperature for 1.5 hours. After the reaction was completed, it was reprecipitated in diethyl ether, and the precipitate was extracted by filtration. Furthermore, it was washed three times with diethyl ether, the obtained white solid was transferred to a round bottom flask, 250 mL of 25% ammonia water was added, and stirred for 4 days. After the reaction was completed, the solvent was distilled off under reduced pressure with an evaporator, and the water was dialyzed against the external liquid two or three times, and lyophilized, thereby obtaining TAPEG as a white solid. The chemical formula of TAPEG produced is shown in formula (Ia). In formula (Ia), n 11 to n 14 are 50 to 60 when the molecular weight of TAPEG is about 10,000 (10 kDa), and 100 to 115 when the molecular weight is about 20,000 (20 kDa).

Figure 105107368-A0202-12-0018-3
Figure 105107368-A0202-12-0018-3

3. TNPEG之合成: 3. Synthesis of TNPEG:

將THPEG(0.2395mmol、4.79g、1.0equiv)溶解於THF,添加0.7mol/L之戊二酸/THF溶液(4.790mmol、6.85mL、20equiv),於Ar存在下攪拌6小時。反應結束後,滴加至2-丙醇,利用離心分離機離心分離3次。將所獲得之白色固體移至300mL之圓底燒瓶,藉由蒸發器 將溶劑減壓蒸餾去除。將殘渣溶解於苯,藉由過濾去除不溶物。將所獲得之濾液經冷凍乾燥而去除溶劑,藉此獲得末端由羧基修飾之白色固體之四-PEG-COOH。將該四-PEG-COOH(0.2165mmol、4.33g、1.0equiv)溶解於THF,添加N-羥基丁二醯亞胺(2.589mmol、0.299g、12equiv)、N,N'-二異丙基丁二醯亞胺(1.732mmol、0.269mL、8.0equiv),於40℃下加熱攪拌3小時。反應結束後,藉由蒸發器將溶劑減壓蒸餾去除。溶解於氯仿,利用飽和食鹽水提取3次,提取氯仿層。進而,利用硫酸鎂進行脫水、過濾後,藉由蒸發器將溶劑減壓蒸餾去除。進行所獲得之殘渣之苯冷凍乾燥,獲得白色固體之TNPEG。所製作之TNPEG之化學式示於式(IIa)。式(IIa)中,關於n21~n24,於TNPEG之分子量為約10,000(10k)時為45~55,於分子量為約20,000(20k)時為90~115。 THPEG (0.2395 mmol, 4.79 g, 1.0 equiv) was dissolved in THF, 0.7 mol/L glutaric acid/THF solution (4.790 mmol, 6.85 mL, 20 equiv) was added, and stirred for 6 hours in the presence of Ar. After the reaction was completed, it was added dropwise to 2-propanol and centrifuged three times using a centrifuge. The obtained white solid was transferred to a 300 mL round bottom flask, and the solvent was distilled off under reduced pressure by an evaporator. The residue was dissolved in benzene, and insoluble materials were removed by filtration. The obtained filtrate was freeze-dried to remove the solvent, thereby obtaining tetra-PEG-COOH as a white solid whose terminal was modified with a carboxyl group. Dissolve the tetra-PEG-COOH (0.2165mmol, 4.33g, 1.0equiv) in THF, add N-hydroxysuccinimide (2.589mmol, 0.299g, 12equiv), N,N'-diisopropylbutane Diimide (1.732 mmol, 0.269 mL, 8.0 equiv) was heated and stirred at 40°C for 3 hours. After the reaction, the solvent was distilled off under reduced pressure with an evaporator. Dissolve in chloroform, extract three times with saturated saline, and extract the chloroform layer. Furthermore, after dehydrating and filtering with magnesium sulfate, the solvent was distilled off under reduced pressure with an evaporator. The obtained residue was freeze-dried to obtain TNPEG as a white solid. The chemical formula of the prepared TNPEG is shown in formula (IIa). In formula (IIa), n 21 to n 24 are 45 to 55 when the molecular weight of TNPEG is about 10,000 (10k), and 90 to 115 when the molecular weight is about 20,000 (20k).

Figure 105107368-A0202-12-0019-4
Figure 105107368-A0202-12-0019-4

[實施例2] [Example 2]

凝膠前驅體團之合成Synthesis of gel precursor mass

以如下方式合成成為凝膠化反應中之前驅體之凝膠前驅體團。 The gel precursor group that becomes the precursor in the gelation reaction is synthesized in the following manner.

(1)凝膠前驅體團1[TAPEG+TNPEG] (1) Gel precursor group 1 [TAPEG+TNPEG]

首先,將於實施例1中合成之TAPEG(1.0×104g/mol)及TNPEG(1.0×104g/mol)分別溶解於等量之81mM之磷酸緩衝液與檸檬酸-磷酸緩衝液。此時,將物質量比設為TAPEG/TNPEG=1/0.23,將整體之聚合物濃度設為60g/L。利用另一容器將所獲得之2份溶液混 合,藉由自轉公轉攪拌機進行脫泡、攪拌。其後,將混合液迅速移至離心管,為了防止乾燥而蓋上蓋後,於室溫下靜置12小時。 First, TAPEG (1.0×10 4 g/mol) and TNPEG (1.0×10 4 g/mol) synthesized in Example 1 were dissolved in equal amounts of 81 mM phosphate buffer and citric acid-phosphate buffer, respectively. At this time, the material mass ratio was set to TAPEG/TNPEG=1/0.23, and the overall polymer concentration was set to 60g/L. The two parts of the obtained solution were mixed in another container, and defoamed and stirred by a rotation and revolution mixer. Thereafter, the mixed solution was quickly transferred to a centrifuge tube, and capped to prevent drying, and then allowed to stand at room temperature for 12 hours.

該步驟中之儲存彈性模數G'與損失彈性模數G"之時間變化示於圖3。於反應之終點,具有G'<G"之關係性,表示為未達到凝膠形成之溶膠狀態之聚合物團。 The time changes of the storage elastic modulus G'and the loss elastic modulus G" in this step are shown in Fig. 3. At the end of the reaction, there is a relationship of G'<G", which means that the gel-formed sol state is not reached Of polymer clusters.

(2)凝膠前驅體團2[SHPEG+MAPEG] (2) Gel precursor group 2 [SHPEG+MAPEG]

使用SHPEG及MAPEG,同樣地合成凝膠前驅體團2。將整體之聚合物濃度設為60g/L。此時,以SHPEG:MAPEG成為(1-r):r之莫耳比之方式,製備包含過量地含有任一種之2種凝膠前驅體團之多個樣品。 Using SHPEG and MAPEG, the gel precursor group 2 was synthesized in the same manner. The overall polymer concentration is set to 60 g/L. At this time, a plurality of samples containing two kinds of gel precursor groups excessively containing either one in such a manner that SHPEG:MAPEG became a molar ratio of (1-r):r were prepared.

[實施例3] [Example 3]

高分子凝膠之合成Synthesis of polymer gel

使用於實施例2中合成之凝膠前驅體團,以如下方式合成高分子凝膠。 Using the gel precursor group synthesized in Example 2, a polymer gel was synthesized as follows.

(1)高分子凝膠1[TAPEG+TNPEG] (1) Polymer gel 1 [TAPEG+TNPEG]

將於實施例2中獲得之凝膠前驅體團1之溶液用水稀釋至25g/L。算出溶液中之未反應之胺基量,以與其等量之方式添加交聯劑(雙(磺基丁二醯亞胺基)戊二酸酯(BS2G)),藉由自轉公轉攪拌機進行脫泡、攪拌。其後,將混合液迅速移至離心管,為了防止乾燥而蓋上蓋後,於室溫下靜置12小時。 The solution of the gel precursor mass 1 obtained in Example 2 was diluted with water to 25 g/L. Calculate the amount of unreacted amine groups in the solution, add the cross-linking agent (bis(sulfobutanediimidyl) glutarate (BS 2 G)) in the same amount as it is, and perform by rotating the revolution mixer Defoam and stir. Thereafter, the mixed solution was quickly transferred to a centrifuge tube, and capped to prevent drying, and then allowed to stand at room temperature for 12 hours.

該步驟中之儲存彈性模數G'與損失彈性模數G"之時間變化示於圖4。於反應之終點,具有G'>G"之關係性,表示藉由凝膠前驅體團交聯而形成了高分子凝膠。 The time changes of the storage elastic modulus G'and the loss elastic modulus G" in this step are shown in Fig. 4. At the end of the reaction, there is a relationship of G'>G", which means cross-linking by the gel precursor group Instead, a polymer gel is formed.

又,改變凝膠前驅體團之濃度而進行凝膠化之情形時之反應時間示於圖5。圖5之縱軸為凝膠化時間tgel(秒),橫軸為高分子凝膠中之高分子含量c(g/L)。圖中之△為由凝膠前驅體團凝膠化之本發明之高 分子凝膠之實施例,○為不使用凝膠前驅體團而藉由先前方法自聚合物單元直接凝膠化之比較例。其結果可知,於由凝膠前驅體團凝膠化之情形時,以較短之反應時間獲得高分子凝膠。特別於高分子含量為8g/L左右之低濃度之情形時,先前方法時需要7小時以上之凝膠化時間,相對於此,使用本發明之凝膠前驅體團時於1.5小時以內凝膠化。又,於較其高濃度區域,於使用凝膠前驅體團之情形時,凝膠化時間未達30分鐘。 In addition, the reaction time when gelation is changed by changing the concentration of the gel precursor mass is shown in FIG. 5. The vertical axis of FIG. 5 is the gelation time t gel (seconds), and the horizontal axis is the polymer content c (g/L) in the polymer gel. △ in the figure is an example of the polymer gel of the present invention gelled by a gel precursor group, ○ is a comparison of direct gelation from a polymer unit by a previous method without using a gel precursor group example. As a result, it can be seen that when the gel precursor group is gelled, a polymer gel is obtained with a shorter reaction time. Especially when the polymer content is low at about 8g/L, the previous method requires a gelation time of more than 7 hours. In contrast, when the gel precursor of the present invention is used, the gel is within 1.5 hours Change. In addition, in the higher concentration region, when the gel precursor group is used, the gelation time is less than 30 minutes.

2)高分子凝膠2[SHPEG+MAPEG] 2) Polymer gel 2 [SHPEG+MAPEG]

使用於實施例2中獲得之凝膠前驅體團2同樣地製成高分子凝膠。分別將SHPEG過量之凝膠前驅體團(10g/L;r=0.37)、及MAPEG過量之凝膠前驅體團(10g/L;r=0.63)利用含有氯化鈉之檸檬酸緩衝液稀釋至6g/L,並等量混合。與圖5同樣地,改變凝膠前驅體團之濃度而進行凝膠化之情形時之反應時間示於圖6。圖中之○為由凝膠前驅體團凝膠化之本發明之高分子凝膠之實施例,□為不使用凝膠前驅體團而藉由先前方法自聚合物單元直接凝膠化之比較例。特別於高分子含量為7g/L左右之低濃度之情形時,使用本發明之凝膠前驅體團時,以3分鐘凝膠化。其表示,能夠於玻璃體手術時,將凝膠前驅體團注入至眼內,於活體內(in vivo)凝膠化。 The gel precursor mass 2 obtained in Example 2 was used to prepare a polymer gel in the same manner. Dilute the gel precursor mass of SHPEG excess (10g/L; r=0.37) and the gel precursor mass of MAPEG excess (10g/L; r=0.63) with citrate buffer containing sodium chloride to 6g/L, mixed in equal amounts. As in FIG. 5, the reaction time when gelation is changed by changing the concentration of the gel precursor mass is shown in FIG. 6. ○ in the figure is an example of the polymer gel of the present invention gelled by a gel precursor group, □ is a comparison of direct gelation from a polymer unit by a previous method without using a gel precursor group example. In particular, when the polymer content is at a low concentration of about 7 g/L, when the gel precursor of the present invention is used, gelation takes 3 minutes. It indicates that the gel precursor can be injected into the eye during vitreous surgery to gel in vivo.

[實施例4] [Example 4]

凝膠前驅體團之物性Physical properties of gel precursor mass

1. 凝膠前驅體團之尺寸 1. The size of the gel precursor mass

測定於實施例2中合成之凝膠前驅體團1之尺寸分佈所得之結果示於圖7。橫軸之Rh為凝膠前驅體團之粒子直徑(nm),縱軸之G(Γ-1)為特性緩和時間分佈函數。其結果可知,凝膠前驅體團之粒子直徑為數百nm,100nm左右者最多。關於實施例2中合成之凝膠前驅體團2,亦獲得大致相同之結果。 The results of measuring the size distribution of the gel precursor mass 1 synthesized in Example 2 are shown in FIG. 7. Rh on the horizontal axis is the particle diameter (nm) of the gel precursor group, and G (Γ -1 ) on the vertical axis is the distribution function of the characteristic relaxation time. As a result, it can be seen that the particle diameter of the gel precursor group is hundreds of nm, and the largest is around 100 nm. Regarding the gel precursor group 2 synthesized in Example 2, approximately the same results were also obtained.

2. 彈性模數 2. Modulus of elasticity

針對溶液中之凝膠前驅體團1,使用流變儀(Physica MCR501,Anton Paar公司製造)進行動態黏彈性測定,算出儲存彈性模數G'及損失彈性模數G"。其結果,1Hz下之G"為0.1<G"<100Pa之範圍,為G'<G"<100 G'。由此,如上述圖3所示,確認於實施例2中獲得之凝膠前驅體團1為未達到凝膠化臨界之結構。關於實施例2中合成之凝膠前驅體團2,亦獲得大致相同之結果。 For the gel precursor mass 1 in solution, dynamic viscoelasticity measurement was performed using a rheometer (Physica MCR501, manufactured by Anton Paar), and the storage elastic modulus G'and the loss elastic modulus G" were calculated. As a result, at 1 Hz The range of G" is 0.1<G"<100Pa, and G'<G"<100 G'. Thus, as shown in FIG. 3 described above, it was confirmed that the gel precursor group 1 obtained in Example 2 had a structure that did not reach the gelation threshold. Regarding the gel precursor group 2 synthesized in Example 2, approximately the same results were also obtained.

3. 碎形維度 3. Fractal dimension

使用各種聚合物單元之初期濃度之情形時測定於凝膠化臨界點之動態黏度特性之結果示於圖8。圖8之縱軸為儲存彈性模數G'(圖中之○)及損失彈性模數G"(圖中之△),橫軸為頻率。(a)~(d)分別為初期濃度之條件。如圖8所示,隨初期濃度變低,G'與G"之冪定律增加。使用該結果,藉由動態定標理論計算凝膠前驅體團之碎形維度。其結果示於圖9。圖9之縱軸為碎形維度,橫軸為初期濃度。由圖提示可知,隨濃度變低,碎形維度D自理論之預測值(圖中之虛線)向下方偏離,形成更稀疏之結構。 The results of measuring the dynamic viscosity characteristics at the critical point of gelation when the initial concentrations of various polymer units are used are shown in FIG. 8. The vertical axis of Fig. 8 is the storage elastic modulus G'(○ in the figure) and the loss elastic modulus G" (△ in the figure), and the horizontal axis is the frequency. (a) to (d) are the conditions of the initial concentration As shown in Figure 8, as the initial concentration becomes lower, the power law of G'and G" increases. Using this result, the fractal dimension of the gel precursor mass is calculated by dynamic calibration theory. The result is shown in Fig. 9. The vertical axis of Fig. 9 is the fragment dimension, and the horizontal axis is the initial concentration. It can be seen from the figure that as the concentration becomes lower, the fractal dimension D deviates downward from the theoretical predicted value (dashed line in the figure), forming a more sparse structure.

[實施例5] [Example 5]

高分子凝膠之物性Physical properties of polymer gel

又,測定於實施例3中獲得之高分子凝膠1之彈性模數之高分子濃度依存性。其結果可知,如圖10所示,於20g/L之低濃度區域且儲存彈性模數G'比400Pa小之低彈性模數區域,彈性模數與高分子含量成正比。其證明藉由使用自凝膠前驅體團凝膠化之方法,於低彈性模數區域亦能夠控制凝膠之彈性模數。 Furthermore, the polymer concentration dependence of the elastic modulus of the polymer gel 1 obtained in Example 3 was measured. As a result, as shown in FIG. 10, in a low-concentration region where the storage elastic modulus G′ is less than 400 Pa in a low-concentration region of 20 g/L, the elastic modulus is proportional to the polymer content. It proves that by using the method of gelation from the precursor gel group, the elastic modulus of the gel can also be controlled in the low elastic modulus region.

同樣地,測定於實施例3中獲得之高分子凝膠2之彈性模數之聚合物濃度依存性。結果示於圖11。圖中之○為由凝膠前驅體團凝膠化之本發明之高分子凝膠之實施例,□為不使用凝膠前驅體團而藉由先 前之方法自聚合物單元直接凝膠化之比較例。於任一情形均提示,本發明之高分子凝膠顯示較高之彈性模數,形成有效之三維網狀結構。 Similarly, the polymer concentration dependence of the elastic modulus of the polymer gel 2 obtained in Example 3 was measured. The results are shown in Figure 11. ○ in the figure is an embodiment of the polymer gel of the present invention gelled by a gel precursor group, □ is used without a gel precursor group Comparative example in which the former method directly gelled from the polymer unit. In any case, it is suggested that the polymer gel of the present invention exhibits a higher elastic modulus and forms an effective three-dimensional network structure.

又,於擬似之半封閉空間,觀測於實施例3中獲得之高分子凝膠1之膨潤之時間變化。將高分子凝膠放入玻璃容器中,添加磷酸緩衝溶液放置一夜。其結果,如圖12所示,於溶液中亦未表現有體積變化。其係提示該高分子凝膠於半封閉空間未膨潤而能夠用於活體內之封閉空間或半封閉空間之可能性之結果。 Furthermore, in a pseudo-closed space, the time change of swelling of the polymer gel 1 obtained in Example 3 was observed. Place the polymer gel in a glass container, add phosphate buffer solution and let stand overnight. As a result, as shown in FIG. 12, there was no volume change in the solution. It is a result of the possibility that the polymer gel is not swollen in a semi-closed space and can be used in a closed space or a semi-closed space in vivo.

進而,針對實施例3中獲得之高分子凝膠2,測定膨潤壓之時間變化之結果示於圖13。圖中之○為由凝膠前驅體團凝膠化之本發明之高分子凝膠之實施例(聚合物濃度10g/L),□為不使用凝膠前驅體團而藉由先前之方法自聚合物單元直接凝膠化之比較例(聚合物濃度140g/L)。如圖13所示,於比較例中隨時間經過而達到12kPa之平衡,但於本發明之高分子凝膠中一直恆定為0.19kPa左右。該結果表示,即便於本發明之高分子凝膠應用於活體內並經過長時間之情形時,亦能夠長期穩定地使用。 Furthermore, for the polymer gel 2 obtained in Example 3, the results of measuring the time change of the swelling pressure are shown in FIG. 13. ○ in the figure is an example of the polymer gel of the present invention gelled by a gel precursor group (polymer concentration 10 g/L), □ is not used by the gel precursor group and is obtained by the previous method. Comparative example of direct gelation of polymer units (polymer concentration 140 g/L). As shown in FIG. 13, in the comparative example, the balance reached 12 kPa with time, but in the polymer gel of the present invention, it is always constant at about 0.19 kPa. This result indicates that the polymer gel of the present invention can be used stably for a long time even when it is applied to a living body for a long period of time.

[實施例6] [Example 6]

凝膠前驅體團之通用性Versatility of gel precursor mass

於各種系中以與四支鏈系同樣之順序製作低濃度凝膠,藉此研究凝膠前驅體團之通用性。 In various systems, a low-concentration gel was produced in the same order as the four-branched system, thereby studying the versatility of the gel precursor group.

[三支鏈系] [Three-branched system]

將分子量同為2.0×105之Tri-APEG(三胺-聚乙二醇)及Tri-NPEG(三-N-羥基-丁二醯亞胺基-聚乙二醇(NHS-PEG))分別溶解於等量之45mM之磷酸緩衝液及檸檬酸-磷酸緩衝液。此時,物質量比設為Tri-APEG/Tri-NPEG=1/0.49,整體之聚合物濃度設為40g/L。將所獲得之2份溶液於另一容器中混合,藉由自轉公轉混合機進行脫泡、攪拌。其後,將混合液迅速移至離心管,為了防止乾燥而蓋上蓋後,於 室溫下靜置12小時。將所獲得之溶液用水稀釋至25g/L。算出溶液中之未反應之胺基量,以與其等量之方式添加交聯劑(雙(磺基丁二醯亞胺基)戊二酸酯(BS2G)),藉由自轉公轉攪拌機進行脫泡、攪拌。其後,將混合液迅速移至離心管,為了防止乾燥而蓋上蓋後,於室溫下靜置12小時。最終,與四支鏈系同樣地獲得凝膠。 Tri-APEG (triamine-polyethylene glycol) and Tri-NPEG (tri-N-hydroxy-butadiene imide-polyethylene glycol (NHS-PEG)) with the same molecular weight of 2.0×10 5 respectively Dissolve in an equal amount of 45mM phosphate buffer and citric acid-phosphate buffer. At this time, the mass ratio was set to Tri-APEG/Tri-NPEG=1/0.49, and the overall polymer concentration was set to 40g/L. The obtained two parts of the solution were mixed in another container, and defoamed and stirred by a rotation and revolution mixer. Thereafter, the mixed solution was quickly transferred to a centrifuge tube, and capped to prevent drying, and then allowed to stand at room temperature for 12 hours. The obtained solution was diluted with water to 25 g/L. Calculate the amount of unreacted amine groups in the solution, add the cross-linking agent (bis(sulfobutanediimidyl) glutarate (BS 2 G)) in the same amount as it is, and perform by rotating the revolution mixer Defoam and stir. Thereafter, the mixed solution was quickly transferred to a centrifuge tube, and capped to prevent drying, and then allowed to stand at room temperature for 12 hours. Finally, the gel was obtained in the same manner as the four-branched system.

[四支鏈/二支鏈系] [Four-Branch/Two-Branch System]

將分子量分別為2.0×105、1.0×105之Tetra-APEG(三胺-聚乙二醇)及Linear-NPEG(線性-N-羥基-丁二醯亞胺基-聚乙二醇(NHS-PEG))分別溶解於等量之42mM之磷酸緩衝液及檸檬酸-磷酸緩衝液。此時,物質量比設為Tri-APEG/Tri-NPEG=1/1.17,整體之聚合物濃度設為40g/L。將獲得之2份溶液於另一容器中混合,藉由自轉公轉混合機進行脫泡、攪拌。其後,將混合液迅速移至離心管,為了防止乾燥而蓋上蓋後,於室溫下靜置12小時。將所獲得之溶液用水稀釋至25g/L。算出溶液中之未反應之胺基量,以與其等量之方式添加交聯劑(雙(磺基丁二醯亞胺基)戊二酸酯(BS2G)),藉由自轉公轉混合機進行脫泡、攪拌。其後,將混合液迅速移至離心管,為了防止乾燥而蓋上蓋後,於室溫下靜置12小時。最終,與四支鏈系同樣地獲得凝膠。 Tetra-APEG (triamine-polyethylene glycol) and Linear-NPEG (linear-N-hydroxy-succinimide-polyethylene glycol (NHS) with molecular weights of 2.0×10 5 and 1.0×10 5 respectively -PEG)) were dissolved in equal amounts of 42 mM phosphate buffer and citric acid-phosphate buffer, respectively. At this time, the mass ratio is set to Tri-APEG/Tri-NPEG=1/1.17, and the overall polymer concentration is set to 40g/L. The two parts of the obtained solution are mixed in another container, and defoamed and stirred by a rotation and revolution mixer. Thereafter, the mixed solution was quickly transferred to a centrifuge tube, and capped to prevent drying, and then allowed to stand at room temperature for 12 hours. The obtained solution was diluted with water to 25 g/L. Calculate the amount of unreacted amine groups in the solution, add the cross-linking agent (bis(sulfobutanediimide) glutarate (BS 2 G)) in the same amount as it is, and rotate the mixer Defoam and stir. Thereafter, the mixed solution was quickly transferred to a centrifuge tube, and capped to prevent drying, and then allowed to stand at room temperature for 12 hours. Finally, the gel was obtained in the same manner as the four-branched system.

三支鏈系及四支鏈/二支鏈系亦以與四支鏈系同樣之順序獲得凝膠,故而可知凝膠前驅體團之通用性較高。 The three-branched system and the four-branched chain/two-branched system are also obtained in the same order as the four-branched system, so it can be seen that the versatility of the gel precursor group is high.

[實施例7] [Example 7]

對小鼠之注入實驗Infusion experiment on mice

按照以下順序,將本發明之高分子凝膠注入至小鼠中。 The polymer gel of the present invention is injected into mice in the following order.

1. 凝膠前驅體團之製備 1. Preparation of gel precursor mass

以四-PEG-馬來醯亞胺(TMPEG)(1.0×104g/mol)及四-PEG-硫醇(TTPEG)(1.0×104g/mol)之物質量比成為如下表所示之方式進行量取,分別溶解於等量之檸檬酸-磷酸緩衝液(pH值5.8,5mM(NaCl, 149mM))。此時,整體之聚合物濃度設為60g/L。將所獲得之2份溶液於離心管中混合,為了防止乾燥而蓋上蓋後,於室溫下靜置12小時。 The mass ratio of tetra-PEG-maleimide (TMPEG) (1.0×10 4 g/mol) and tetra-PEG-thiol (TTPEG) (1.0×10 4 g/mol) becomes the following table It was measured in the same way and dissolved in equal amounts of citric acid-phosphate buffer (pH 5.8, 5mM (NaCl, 149mM)). At this time, the overall polymer concentration was set to 60 g/L. The two obtained solutions were mixed in a centrifuge tube, and capped to prevent drying, and then allowed to stand at room temperature for 12 hours.

Figure 105107368-A0202-12-0025-5
Figure 105107368-A0202-12-0025-5

2. 高分子凝膠之製備 2. Preparation of polymer gel

以高分子凝膠之總量成為2mL、聚合物濃度分別成為13g/L(組1)、11g/L(組2)之方式量取凝膠前驅體團溶液,注入至注射器。又,關於組1及組2,算出各自之溶液中之未反應之馬來醯亞胺基、硫醇基之量,以與其等量之方式分別量取交聯劑(DL-二硫蘇糖醇及1,8-雙馬來醯亞胺二甘醇)。將該交聯劑分別溶解於高分子凝膠之總量及凝膠前驅體團之差量之檸檬酸-磷酸緩衝液(pH值5.8,5mM(NaCl,149mM)),注入至與上述注射器不同之另一注射器。使用三向閥混合兩種溶液,向打麻醉之小鼠之後背注入1mL。又,作為比較例,準備將僅TMPEG(單體A)、僅TTPEG(單體B)以成為15g/L之方式分別溶解於檸檬酸-磷酸緩衝液(pH值5.8,5mM(NaCl,149mM))而成者、及僅檸檬酸-磷酸緩衝液(pH值5.8,5mM(NaCl,149mM))(對照樣品)之試樣,分別向打麻醉之小鼠注入1mL。自注入起1週後觀察小鼠之組織。 The gel precursor mass solution was measured in such a way that the total amount of polymer gel became 2 mL and the polymer concentration became 13 g/L (group 1) and 11 g/L (group 2), respectively, and injected into the syringe. In addition, regarding Group 1 and Group 2, the amounts of unreacted maleimide groups and thiol groups in the respective solutions were calculated, and the cross-linking agent (DL-dithiothreose) was measured separately in an equivalent amount Alcohol and 1,8-bismaleimide diethylene glycol). Dissolve the cross-linking agent in the total amount of polymer gel and the difference between the gel precursor group and the citric acid-phosphate buffer (pH value 5.8, 5mM (NaCl, 149mM)), and inject it into a syringe different from the above Another syringe. The two solutions were mixed using a three-way valve, and 1 mL was injected into the back of anesthetized mice. As a comparative example, TMPEG (monomer A) and TTPEG (monomer B) were dissolved in citric acid-phosphate buffer (pH 5.8, 5 mM (NaCl, 149 mM), respectively, so as to be 15 g/L. ), and samples of only citric acid-phosphate buffer (pH value 5.8, 5mM (NaCl, 149mM)) (control sample), were injected into the anesthetized mice 1mL. One week after the injection, the tissues of the mice were observed.

其結果,組1及組2均未出現凝膠之分解或排斥反應,自注入起1週後於皮膚下確認到凝膠之存在。另一方面,於僅注入單體之情形時,不伴有毒作用而分解。所有之小鼠正常,體重無變化。 As a result, neither the group 1 nor the group 2 showed decomposition or rejection of the gel, and the presence of the gel was confirmed under the skin 1 week after the injection. On the other hand, when only the monomer is injected, it is decomposed without toxic effects. All mice were normal, with no change in body weight.

Claims (24)

一種高分子凝膠之製造方法,其特徵在於:其係凝膠前驅體團相互交聯而形成三維網狀結構之高分子凝膠之製造方法,且包括:a)使未達臨界凝膠化濃度之單體單元或聚合物單元交聯而形成上述凝膠前驅體團之步驟,其中,上述凝膠前驅體團於儲存彈性模數G'與損失彈性模數G"具有G'<G"之關係性;及b)藉由利用交聯劑使上述凝膠前驅體團相互交聯而獲得具有三維網狀結構之凝膠之步驟。 A method for manufacturing a polymer gel, characterized in that it is a method for manufacturing a polymer gel in which gel precursor groups are cross-linked with each other to form a three-dimensional network structure, and includes: a) gelation that is not critical The step of crosslinking monomer units or polymer units at a concentration to form the gel precursor group, wherein the gel precursor group has G'<G" in storage elastic modulus G'and loss elastic modulus G" Relationship; and b) a step of obtaining a gel having a three-dimensional network structure by cross-linking the aforementioned gel precursor groups with a cross-linking agent. 如請求項1之製造方法,其中上述損失彈性模數G"於1Hz之頻率下為0.005~5Pa之範圍。 As in the manufacturing method of claim 1, the above-mentioned loss elastic modulus G" is in the range of 0.005 to 5 Pa at a frequency of 1 Hz. 如請求項1或2之製造方法,其中上述凝膠前驅體團具有1.5~2.5之碎形維度。 The manufacturing method according to claim 1 or 2, wherein the gel precursor mass has a fragmentary dimension of 1.5 to 2.5. 如請求項1或2之製造方法,其中上述凝膠前驅體團具有10~1000nm之範圍之直徑。 The manufacturing method according to claim 1 or 2, wherein the aforementioned gel precursor group has a diameter in the range of 10 to 1000 nm. 如請求項1或2之製造方法,其中上述凝膠為50g/L以下之高分子含量。 The manufacturing method according to claim 1 or 2, wherein the gel is a polymer content of 50 g/L or less. 如請求項1或2之製造方法,其中上述單體單元係具有乙烯基骨架者,或者上述聚合物單元具有聚乙二醇骨架或聚乙烯骨架。 The manufacturing method according to claim 1 or 2, wherein the monomer unit has a vinyl skeleton, or the polymer unit has a polyethylene glycol skeleton or a polyethylene skeleton. 如請求項1或2之製造方法,其中上述凝膠前驅體團包含於側鏈或末端具有1個以上之親核性官能基之第1聚合物單元、及於側鏈或末端具有1個以上之親電子性官能基之第2聚合物單元。 The manufacturing method according to claim 1 or 2, wherein the gel precursor group includes a first polymer unit having at least one nucleophilic functional group at the side chain or terminal, and at least one at the side chain or terminal The second polymer unit of the electrophilic functional group. 如請求項7之製造方法,其中上述親核性官能基選自由胺基、-SH、及-CO2PhNO2所組成之群,上述親電子性官能基選自由N-羥基-丁二醯亞胺(NHS)基、磺基丁二醯亞胺基、馬來醯亞胺 基、鄰苯二甲醯亞胺基、咪唑基、丙烯醯基、及硝基苯基所組成之群。 The manufacturing method according to claim 7, wherein the nucleophilic functional group is selected from the group consisting of an amine group, -SH, and -CO 2 PhNO 2 , and the electrophilic functional group is selected from N-hydroxy-butadiene A group consisting of an amine (NHS) group, a sulfobutanediimide group, a maleimide group, a phthalimide group, an imidazolyl group, an acryloyl group, and a nitrophenyl group. 如請求項7之製造方法,其中上述凝膠前驅體團包含第1凝膠前驅體團及第2凝膠前驅體團,上述第1凝膠前驅體團之第1聚合物單元之含量比第2聚合物單元之含量多,上述第2凝膠前驅體團之第2聚合物單元之含量比第1聚合物單元之含量多。 The manufacturing method according to claim 7, wherein the gel precursor group includes a first gel precursor group and a second gel precursor group, and the content of the first polymer unit of the first gel precursor group is higher than that of the first 2 The content of the polymer unit is large, and the content of the second polymer unit of the second gel precursor group is greater than the content of the first polymer unit. 如請求項1或2之製造方法,其中上述步驟b)以1小時以內之反應時間進行。 The manufacturing method according to claim 1 or 2, wherein the above step b) is performed with a reaction time within 1 hour. 如請求項1或2之製造方法,其中上述步驟b)中之交聯劑係雙(磺基丁二醯亞胺基)戊二酸酯(BS2G)或DL-二硫蘇糖醇(DTT)、或於末端具有硫醇基之合成肽。 The manufacturing method according to claim 1 or 2, wherein the cross-linking agent in the above step b) is bis(sulfosuccinimide) glutarate (BS 2 G) or DL-dithiothreitol ( DTT), or a synthetic peptide with a thiol group at the end. 一種凝膠前驅體團,其係使未達臨界凝膠化濃度之單體單元或聚合物單元交聯而獲得者,且包含溶劑,於儲存彈性模數G'與損失彈性模數G"具有G'<G"之關係性,並具有10~1000nm之範圍之直徑。 A gel precursor group obtained by cross-linking monomer units or polymer units that have not reached the critical gelation concentration, and containing a solvent, having storage elastic modulus G'and loss elastic modulus G" G'<G" is related and has a diameter in the range of 10~1000nm. 如請求項12之凝膠前驅體團,其中上述損失彈性模數G"於1Hz之頻率下為0.005~5Pa之範圍。 As in the gel precursor mass of claim 12, the above-mentioned loss elastic modulus G" is in the range of 0.005 to 5 Pa at a frequency of 1 Hz. 如請求項12或13之凝膠前驅體團,其中上述凝膠前驅體團具有1.5~2.5之碎形維度。 The gel precursor mass according to claim 12 or 13, wherein the gel precursor mass has a fragmentary dimension of 1.5~2.5. 如請求項12或13之凝膠前驅體團,其中上述單體單元係具有乙烯基骨架者,或者上述聚合物單元具有聚乙二醇骨架或聚乙烯骨架。 The gel precursor group according to claim 12 or 13, wherein the monomer unit has a vinyl skeleton, or the polymer unit has a polyethylene glycol skeleton or a polyethylene skeleton. 如請求項12或13之凝膠前驅體團,其包含於側鏈或末端具有1個以上之親核性官能基之第1聚合物單元、及於側鏈或末端具有1個以上之親電子性官能基之第2聚合物單元。 The gel precursor group according to claim 12 or 13, which comprises a first polymer unit having more than one nucleophilic functional group on the side chain or terminal, and more than one electrophilic group on the side chain or terminal The second polymer unit of the functional group. 如請求項16之凝膠前驅體團,其中上述親核性官能基選自由胺基、-SH、及-CO2PhNO2所組成之群,上述親電子性官能基選自由N-羥基-丁二醯亞胺(NHS)基、磺基丁二醯亞胺基、馬來醯亞胺基、鄰苯二甲醯亞胺基、咪唑基、丙烯醯基、及硝基苯基所組成之群。 The gel precursor group according to claim 16, wherein the nucleophilic functional group is selected from the group consisting of amine group, -SH, and -CO 2 PhNO 2 , and the electrophilic functional group is selected from N-hydroxy-butyl A group consisting of diimide (NHS) group, sulfobutanediimide group, maleimide group, phthalimide group, imidazolyl group, acryloyl group, and nitrophenyl group . 一種高分子凝膠,其係藉由如請求項1至11中任一項之製造方法所獲得。 A polymer gel obtained by the manufacturing method according to any one of claims 1 to 11. 一種高分子凝膠,其特徵在於:其係藉由聚合物單元相互交聯而形成三維網狀結構者,且包含溶劑,具有50g/L以下之高分子含量、於1Hz之頻率下為1~10000Pa之儲存彈性模數G'、及1.5~3.0之碎形維度,且其係於水溶液中30~40℃之範圍內之上述高分子凝膠之體積相對於凝膠製成時之體積為90~500%之體積變化之範圍之膨潤度,並具有0.001~5kPa之膨潤壓。 A polymer gel, characterized in that it is formed by a cross-linking of polymer units to form a three-dimensional network structure, and contains a solvent, has a polymer content of 50g/L or less, at a frequency of 1Hz is 1 ~ The storage elastic modulus G'of 10000Pa and the fractal dimension of 1.5~3.0, and the volume of the above polymer gel in the range of 30~40℃ in the aqueous solution is 90% relative to the volume when the gel is made The swelling degree in the range of ~500% volume change, and has a swelling pressure of 0.001~5kPa. 如請求項19之高分子凝膠,其具有1~100Pa之損失彈性模數G"。 The polymer gel of claim 19 has a loss elastic modulus G" of 1-100 Pa. 如請求項19或20之高分子凝膠,其中上述聚合物單元具有聚乙二醇骨架或聚乙烯骨架。 The polymer gel according to claim 19 or 20, wherein the polymer unit has a polyethylene glycol skeleton or a polyethylene skeleton. 如請求項19或20之高分子凝膠,其中上述聚合物單元包含於側鏈或末端具有1個以上之親核性官能基之第1聚合物單元、及於側鏈或末端具有1個以上之親電子性官能基之第2聚合物單元。 The polymer gel according to claim 19 or 20, wherein the polymer unit includes a first polymer unit having one or more nucleophilic functional groups at the side chain or terminal, and one or more at the side chain or terminal The second polymer unit of the electrophilic functional group. 如請求項22之高分子凝膠,其中上述親核性官能基選自由胺基、-SH、及-CO2PhNO2所組成之群,上述親電子性官能基選自由N-羥基-丁二醯亞胺(NHS)基、磺基丁二醯亞胺基、馬來醯亞胺基、鄰苯二甲醯亞胺基、咪唑基、丙烯醯基、及硝基苯基所組成之群。 The polymer gel according to claim 22, wherein the nucleophilic functional group is selected from the group consisting of amine group, -SH, and -CO 2 PhNO 2 , and the electrophilic functional group is selected from N-hydroxy-butane The group consisting of amide imine (NHS) group, sulfobutane imide group, maleimide group, phthalimide group, imidazolyl group, acryl group, and nitrophenyl group. 如請求項19之高分子凝膠,其中上述膨潤度為100~200%之範圍,上述膨潤壓為0.1~2kPa。 The polymer gel according to claim 19, wherein the swelling degree is in the range of 100 to 200%, and the swelling pressure is 0.1 to 2 kPa.
TW105107368A 2015-03-10 2016-03-10 Method for producing a low-concentration gel by using a precursor gel cluster, and a gel obtained by the method TWI683842B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015047388 2015-03-10
JP2015-047388 2015-03-10

Publications (2)

Publication Number Publication Date
TW201714925A TW201714925A (en) 2017-05-01
TWI683842B true TWI683842B (en) 2020-02-01

Family

ID=56879553

Family Applications (1)

Application Number Title Priority Date Filing Date
TW105107368A TWI683842B (en) 2015-03-10 2016-03-10 Method for producing a low-concentration gel by using a precursor gel cluster, and a gel obtained by the method

Country Status (6)

Country Link
US (1) US10550225B2 (en)
EP (1) EP3269755A4 (en)
JP (1) JP6712081B2 (en)
CN (1) CN107428930B (en)
TW (1) TWI683842B (en)
WO (1) WO2016143647A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6692021B2 (en) * 2016-01-06 2020-05-13 国立大学法人 東京大学 Gel material for ophthalmic treatment
US20210155799A1 (en) * 2018-07-31 2021-05-27 The University Of Tokyo Polymer gel having sponge-like porous structure
EP3712243A1 (en) * 2019-03-20 2020-09-23 Ricoh Company, Ltd. Liquid set for droplet discharging apparatus
AU2020240750B2 (en) 2019-03-20 2023-07-06 Ricoh Company, Ltd. Cell culture carrier, and method and device for producing same
JP7203313B2 (en) * 2019-03-20 2023-01-13 国立大学法人 東京大学 hydrogel composition
JP2021078377A (en) * 2019-11-15 2021-05-27 株式会社リコー Laminate
EP4098285A4 (en) * 2020-01-28 2024-02-28 The University of Tokyo Gel material for regenerative medicine
WO2021199950A1 (en) * 2020-03-31 2021-10-07 テルモ株式会社 Artificial blood vessel and method for manufacturing artificial blood vessel
JP2021176422A (en) * 2020-05-08 2021-11-11 国立大学法人 東京大学 Polymer material kit for hemostasis

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120122949A1 (en) * 2008-12-19 2012-05-17 The University Of Tokyo Ultra-high strength injectable hydrogel and process for producing the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842209B1 (en) 1995-07-28 2006-10-11 Genzyme Corporation Multiblock biodegradable hydrogels for use as controlled release agents for drugs and tissue treatment agents
US6312725B1 (en) * 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
WO2000064977A1 (en) * 1999-04-26 2000-11-02 California Institute Of Technology In situ forming hydrogels
JP2007111300A (en) * 2005-10-21 2007-05-10 National Institute For Materials Science Locally dosed type controlled-release in-vivo degradable/absorbable medical material
CA2637635A1 (en) * 2006-01-18 2007-07-26 Next21 K.K. Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier
JP2010519183A (en) * 2007-02-06 2010-06-03 インセプト エルエルシー Polymerization using protein precipitation for elution of physiological solutions
US20080220047A1 (en) * 2007-03-05 2008-09-11 Sawhney Amarpreet S Low-swelling biocompatible hydrogels
CN201427420Y (en) 2008-08-29 2010-03-24 纸艺制品有限公司 Paper-based composite material
US20100100123A1 (en) 2008-10-17 2010-04-22 Confluent Surgical, Inc. Hemostatic implant
US9889230B2 (en) 2008-10-17 2018-02-13 Covidien Lp Hemostatic implant
US8591950B2 (en) * 2010-05-27 2013-11-26 Covidien Lp Hydrogel implants with varying degrees of crosslinking
US8591929B2 (en) 2010-05-27 2013-11-26 Covidien Lp Hydrogel implants with varying degrees of crosslinking
US8883185B2 (en) 2010-05-27 2014-11-11 Covidien Lp Hydrogel implants with varying degrees of crosslinking
US8734930B2 (en) 2010-05-27 2014-05-27 Covidien Lp Hydrogel implants with varying degrees of crosslinking
US8968783B2 (en) 2010-05-27 2015-03-03 Covidien Lp Hydrogel implants with varying degrees of crosslinking
US8734824B2 (en) 2010-05-27 2014-05-27 Covidien LLP Hydrogel implants with varying degrees of crosslinking
US8754564B2 (en) 2010-05-27 2014-06-17 Covidien Lp Hydrogel implants with varying degrees of crosslinking
JPWO2012035598A1 (en) 2010-09-13 2014-01-20 株式会社グツドマン MEDICAL MATERIAL, DRIED BODY AND METHOD FOR PRODUCING THEM
JP2015137430A (en) * 2014-01-20 2015-07-30 国立大学法人福井大学 Gel fiber and nonwoven fabric thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120122949A1 (en) * 2008-12-19 2012-05-17 The University Of Tokyo Ultra-high strength injectable hydrogel and process for producing the same

Also Published As

Publication number Publication date
JPWO2016143647A1 (en) 2017-12-21
CN107428930B (en) 2020-01-17
EP3269755A4 (en) 2018-11-21
TW201714925A (en) 2017-05-01
US20180030205A1 (en) 2018-02-01
US10550225B2 (en) 2020-02-04
JP6712081B2 (en) 2020-06-17
CN107428930A (en) 2017-12-01
EP3269755A1 (en) 2018-01-17
WO2016143647A1 (en) 2016-09-15

Similar Documents

Publication Publication Date Title
TWI683842B (en) Method for producing a low-concentration gel by using a precursor gel cluster, and a gel obtained by the method
Yang et al. Highly efficient self‐healable and dual responsive cellulose‐based hydrogels for controlled release and 3D cell culture
US20170129999A1 (en) PH Responsive Self-Healing Hydrogels Formed By Boronate-Catechol Complexation
JP7272672B2 (en) Polymer gel with sponge-like porous structure
US9873769B2 (en) Thiolated PEG-PVA hydrogels
WO2017119296A1 (en) Gel material for ophthalmic treatment use
WO2013039071A1 (en) Gel composition containing an ionic liquid, thin film gel, and production method thereof
García-Astrain et al. Synthesis and behavior of click cross-linked alginate hydrogels: Effect of cross-linker length and functionality
Bingol et al. Stimuli‐responsive poly (hydroxyethyl methacrylate) hydrogels from carboxylic acid‐functionalized crosslinkers
WO2014157186A1 (en) Novel low-swellling-degree hydrogel containing temperature -responsive polymer
JP6939607B2 (en) Compositions and their uses
Chen et al. In situ forming hydrogels based on oxidized hydroxypropyl cellulose and Jeffamines
JP7203313B2 (en) hydrogel composition
WO2021153489A1 (en) Gel material for regenerative medicine
Kim Development of Multifunctional Polymer-based Hydrogel with Controllable Physicochemical Properties for Biomedical Engineering

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees